10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☑          QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019

OR

☐          TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

Commission File Number 000-53601

TRUE NATURE HOLDING, INC.

(Exact name of registrant as specified in its charter)

Delaware	87-0496850
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
1355 Peachtree Street, Suite 1150 Atlanta, Georgia	30309
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (844) 383-8689

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ☑   No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ☑   No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐		Accelerated filer	☐
Non-accelerated filer	☐	(Do not check if a smaller reporting company)	Smaller reporting company	☑
Emerging growth company	☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐   No  ☑

Securities registered pursuant to Section 12(b) of the Act: None.

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

As of August 8, 2019, 41,625,627 shares of the registrant’s common stock, $0.01 par value, were outstanding. 

Table of Contents

PART I – FINANCIAL INFORMATION
ITEM 1.	CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.	1
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.	22
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.	26
ITEM 4.	CONTROLS AND PROCEDURES.	26
PART II – OTHER INFORMATION
ITEM 1.	LEGAL PROCEEDINGS.	27
ITEM 1A.	RISK FACTORS.	28
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.	28
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES.	28
ITEM 4.	MINE SAFETY DISCLOSURES.	28
ITEM 5.	OTHER INFORMATION.	28
ITEM 6.	EXHIBITS.	28
SIGNATURES		29

PART I – FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS.

TRUE NATURE HOLDING, INC.

Condensed Consolidated Balance Sheets

	June 30,			December 31,
	2019			2018
ASSETS
Current assets
Cash and cash equivalents	$	284		$	1,304
Prepaid expenses		-			2,500
Total current assets		284			3,804
Total Assets		284			3,804
LIABILITIES AND (DEFICIENCY IN) STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable		811,300			794,466
Accrued liabilities		184,044			117,085
Due to related parties		50,099			13,948
Accrued interest		78,504			60,381
Notes payable		-			30,000
Convertible notes payable, net of discount of $117,198 and $86,520		406,995			247,590
Convertible note payable, in default		122,166			196,270
Note payable, related party - current portion		198,000			75,000
Total current liabilities		1,851,108			1,534,740
Notes payable, related party - non current portion		-			123,000
Total Liabilities		1,851,108			1,657,740
Commitments and contingencies		-			-
Stockholders' equity (deficit)
Preferred stock, $0.01 par value, 100,000,000 shares authorized, no shares issued or outstanding as of June 30, 2019 and December 31, 2018		-			-
Common stock, $0.01 par value, 500,000,000 shares authorized, 39,077,259 and 31,598,236 shares issued and outstanding as of June 30, 2019 and December 31, 2018		390,774			315,982
Additional paid-in capital		6,370,513			5,684,208
Stock payable		37,186			37,186
Accumulated deficit		(8,649,297	)		(7,691,312	)
Total (deficiency in) stockholders' equity		(1,850,824	)		(1,653,936	)
Total liabilities and stockholders' equity	$	284		$	3,804

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

1

TRUE NATURE HOLDING, INC.

Unaudited Condensed Consolidated Statements of Operations

	For the Three Months Ended			For the Three Months Ended			For the Six Months Ended			For the Six Months Ended
	June 30,			June 30,			June 30,			June 30,
	2019			2018			2019			2018
Revenue	$	-		$	-		$	-		$	-
Operating expenses:
General and administrative		226,250			276,026			447,501			329,305
Total operating expenses		226,250			276,026			447,501			329,305
Net Operating Loss		(226,250	)		(276,026	)		(447,501	)		(329,305	)
Other income (expense):
Interest expense		(164,504	)		(9,505	)		(324,901	)		(16,666	)
Loss on conversion of accounts payable		-			(36,100	)		-			(36,100	)
Loss on legal settlement		(26,924	)		-			(26,924	)		-
Loss on conversion of notes		(58,935	)		-			(158,659	)		-
Total other expense		(250,363	)		(45,605	)		(510,484	)		(52,766	)
Loss before provision for income taxes		(476,613	)		(321,631	)		(957,985	)		(382,071	)
Provision for income taxes		-			-			-			-
Net loss	$	(476,613	)		(321,631	)		(957,985	)		(382,071	)
Net loss per share - basic	$	(0.01	)	$	(0.01	)	$	(0.03	)	$	(0.02	)
Net loss per share - diluted	$	(0.01	)	$	(0.01	)	$	(0.03	)	$	(0.02	)
Weighted average shares outstanding - basic		33,986,267			21,702,295			33,188,078			21,397,055
Weighted average shares outstanding - diluted		33,983,267			21,702,295			33,188,078			21,397,055

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

2

TRUE NATURE HOLDING, INC.

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit

	FOR THE THREE MONTHS ENDED JUNE 30
	Common Stock							Stock		Accumulated
	Shares		Amount		APIC			Payable		Deficit			Total
Balance, March 31, 2018		20,835,997	$	208,360	$	4,841,045		$	39,886	$	(6,336,599	)	$	(1,247,308	)
Stock issued for services		3,075,000		30,750		214,830								245,580
Stock to be issued for services									22,900					22,900
Stock issued as compensation		300,000		3,000		10,740								13,740
Imputed interest		-		-		2,250								2,250
Net loss											(321,631	)		(321,631	)
Balance, June 30, 2018		24,210,997	$	242,110	$	5,068,865		$	62,786	$	(6,658,230	)	$	(1,284,469	)
Balance, March 31, 2019		33,316,861		333,168		5,993,643			37,186		(8,172,684	)		(1,808,687	)
Stock issued to employees subject to vesting		1,000,000		10,000		(10,000	)		-		-			-
Stock issued for conversion of notes payable		3,359,444		33,594		131,831			-		-			165,425
Shares issued for legal settlement		1,401,224		14,012		87,016			-		-			101,028
Discount on notes payable due to conversion feature		-		-		143,555			-		-			143,555
Vesting of shares issued to employees		-		-		22,218			-		-			22,218
Imputed interest		-		-		2,250			-					2,250
Net loss for the period		-		-		-			-		(476,613	)		(476,613	)
Balance, June 30, 2019		39,077,529	$	390,774	$	6,370,513		$	37,186	$	(8,649,297	)	$	(1,850,824	)

	FOR THE SIX MONTHS ENDED JUNE 30
	Common Stock									Stock		Accumulated
	Shares			Amount			APIC			Payable		Deficit			Total
Balance, December 31, 2017		18,930,874		$	189,309		$	4,659,713		$	39,886	$	(6,276,159	)	$	(1,387,251	)
Stock issued for services		3,105,628			31,056			217,709			-		-			248,765
Stock issued for conversion of accounts payable		527,064			5,271			49,544			-		-			54,815
Stock issued as compensation		1,647,431			16,474			137,399			-		-			153,873
Stock to be issued for services		-			-			-			22,900		-			22,900
Imputed interest		-			-			4,500			-		-			4,500
Net loss		-			-			-			-		(382,071	)		(382,071	)
Balance, June 30, 2018		24,210,997		$	242,110		$	5,068,865		$	62,786	$	(6,658,230	)	$	(1,284,469	)
Balance, December 31, 2018		31,598,236		$	315,982		$	5,684,208		$	37,186	$	(7,691,312	)	$	(1,653,936	)
Stock issued for services		200,000			2,000			15,480			-		-			17,480
Stock issued to employees subject to vesting		1,000,000			10,000			(10,000	)		-		-			-
Stock issued for conversion of notes payable		5,278,069			52,780			302,629			-		-			355,409
Stock issued for legal settlement		1,401,224			14,012			87,016			-		-			101,028
Discount on notes payable due to conversion feature		-			-			223,087			-		-			223,087
Discount on notes payable due to warrants		-			-			34,500			-		-			34,500
Cancellation of shares		(400,000	)		(4,000	)		4,000			-		-			-
Vesting of shares issued to employees		-			-			25,093								25,093
Imputed interest		-			-			4,500			-		-			4,500
Net loss for the period		-			-			-			-		(957,985	)		(957,985	)
Balance, June 30, 2019		39,077,529		$	390,774		$	6,370,513		$	37,186	$	(8,649,297	)	$	(1,850,824	)

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

3

TRUE NATURE HOLDING, INC.

Unaudited Condensed Consolidated Statement of Cash Flows

	For the			For the
	Six Months Ended			Six Months Ended
	June 30,			June 30,
	2019			2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(957,985	)	$	(382,071	)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on conversion of notes payable to common stock		158,659			-
Loss on legal settlement		26,924			-
Loss on conversion of accrued expenses		-			36,100
Shares issued for extension of note payable
Imputed interest		4,500			4,500
Amortization of discount on notes payable		261,035
Stock based compensation		42,573			47,620
Changes in assets and liabilities:
Prepaid expenses		2,500			-
Accounts payable		16,834			214,597
Accrued liabilities		66,959			50,000
Deferred revenue		-			1,000
Due to related parties		36,151			(24,563	)
Accrued interest		37,508			9,822
Net cash used in operating activities		(304,342	)		(42,995	)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable, net of discount		313,558			-
Principal payments on notes payable		(10,236	)		-
Advances from related parties		-			44,103
Net cash provided by financing activities		303,322			44,103
Net increase (decrease) in cash and cash equivalents		(1,020	)		1,108
Cash and cash equivalents at beginning of period		1,304			-
Cash and cash equivalents at end of period	$	284		$	1,108
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	$	2,236		$	-
Income taxes paid	$	-		$	-
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued for satisfaction of payables	$	-		$	396,633
Par value of shares returned for cancellation	$	4,000		$	-
Stock issued for debt conversion	$	196,750		$	-
Stock issued for legal settlement	$	74,104		$	-
Discount due to warrants	$	34,500		$	-
Beneficial conversion feature	$	223,087		$	-

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

4

TRUE NATURE HOLDING, INC.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 1 – Description of Business

Company Overview

True Nature Holding, Inc. (the “Company,” “we,” “us,” or “our”), previously known as Trunity Holdings, Inc., a Delaware corporation, became a publicly-traded company through a reverse triangular merger with Brain Tree International, Inc., a Utah corporation (“BTI”). Trunity Holdings, Inc. was the parent company of our educational business, named Trunity, Inc., which was formed on July 28, 2009 through the acquisition of certain intellectual property from its three founders. On December 9, 2015 the Company made a decision to restructure Trunity Holdings, Inc., having acquired Newco4pharmacy, LLC, a development stage business aimed at a roll-up of compounding pharmacy businesses. As a part of such restructuring, we competed a “spin out” transaction of our educational business line to our shareholders as of December 31, 2015.

Our business during 2018, which has continued into 2019 is focused in the area of software and solutions, predominantly in the healthcare sector, generally described as the healthcare information and technology (HCIT) market. We announced plans for a personal healthcare records (PHR) application, SimpleHIPAA, which will allow individuals to track their personal healthcare information. This type of application is intended to include information from the individual, as well as data from healthcare providers extracted from their electronic healthcare records (EHR) systems. Data from individuals might include manual input or from personal devices such as watches, activity trackers and diagnostic devices such as glucose meters or blood pressure measuring devices. Information from healthcare providers might include data gathered from regular doctor visits, specialized care, or even a simple as prescription information from a pharmacy.

While this project continues, we are also evaluating other applications, generally, but not exclusively in the healthcare area. We believe that new technologies such as voice recognition, virtual reality and robotics will all provide excellent vehicles to update traditional information management systems and will find quick acceptance in the healthcare field as well as other large and more traditional markets. We believe the need for compliance in other industries, similar to the need in healthcare for HIPAA and data security represents opportunity for growth over and above our healthcare efforts.

Within the healthcare arena one of the most active areas involves software that provides “interoperability”, the interfacing of systems and data so that information may be shared effectively. We believe there will be many opportunities in this application area, as older systems are integrated with newer, or more specialized systems, but we have not taken any actions in pursuit of these opportunities and no guarantee can be made if we enter this space, that we will be successful. These same needs exist in other market areas and we may consider applications for these markets as well as our healthcare efforts.

Note 2 – Summary of Significant Accounting Policies

Basis of Accounting – The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to interim financial reporting as prescribed by the Securities and Exchange Commission (the “SEC”). The results for the interim periods are not necessarily indicative of results for the entire year. These interim financial statements do not include all disclosures required by U.S. generally accepted accounting principles (“GAAP”), and should be read in conjunction with the consolidated financial statements and notes thereto filed with the SEC in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018. In the opinion of management, the unaudited Condensed Consolidated Financial Statements contained in this report include all known accruals and adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods reported herein. Any such adjustments are of a normal recurring nature.

Use of Estimates - The preparation of these financial statements requires our management to make estimates and assumptions about future events that affect the amounts reported in the financial statements and related notes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment.

Comprehensive Loss – Comprehensive income (loss) as defined includes all changes in equity during a period from non-owner sources. Items included in the Company’s comprehensive loss consist of unrealized gains (losses) on securities.

Cash -All highly liquid investments with a maturity date of three months or less at the date of purchase are cash equivalents.   

5

Revenue Recognition – On January 1, 2018, we adopted Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (ASC) Topic 605, Revenue Recognition (Topic 605). Results for reporting periods beginning after January 1, 2018 are presented under Topic 606. The impact of adopting the new revenue standard was not material to our financial statements and there was no adjustment to beginning retained earnings on January 1, 2018.

Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

We determine revenue recognition through the following steps:

● identification of the contract, or contracts, with a customer;

● identification of the performance obligations in the contract;

● determination of the transaction price;

● allocation of the transaction price to the performance obligations in the contract; and

● recognition of revenue when, or as, we satisfy a performance obligation.

Stock-Based Compensation-We recognize the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation cost for stock options are estimated at the grant date based on each option’s fair-value as calculated by the Black-Scholes-Merton (“BSM”) option-pricing model. Share-based compensation arrangements may include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.

Equity instruments issued to those other than employees are recorded on the basis of the fair value of the instruments. In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant.

Convertible Instruments-The Company reviews the terms of convertible debt and equity instruments to determine whether there are conversion features or embedded derivative instruments including embedded conversion options that are required to be bifurcated and accounted for separately as a derivative financial instrument. In circumstances where the convertible instrument contains more than one embedded derivative instrument, including conversion options that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single compound instrument. Also, in connection with the sale of convertible debt and equity instruments, the Company may issue free standing warrants that may, depending on their terms, be accounted for as derivative instrument liabilities, rather than as equity. When convertible debt or equity instruments contain embedded derivative instruments that are to be bifurcated and accounted for separately, the total proceeds allocated to the convertible host instruments are first allocated to the fair value of the bifurcated derivative instrument. The remaining proceeds, if any, are then allocated to the convertible instruments themselves, usually resulting in those instruments being recorded at a discount from their face amount. When the Company issues debt securities, which bear interest at rates that are lower than market rates, the Company recognizes a discount, which is offset against the carrying value of the debt. Such discount from the face value of the debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to income. In addition, certain conversion features are recognized as beneficial conversion features to the extent the conversion price as defined in the convertible note is less than the closing stock price on the issuance of the convertible notes.

Common Stock Purchase Warrants-The Company accounts for common stock purchase warrants in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 815, Accounting for Derivative Instruments and Hedging Activities. As is consistent with its handling of stock compensation and embedded derivative instruments, the Company’s cost for stock warrants is estimated at the grant date based on each warrant’s fair-value as calculated by the BSM option-pricing model value method for valuing the impact of the expense associated with these warrants.

6

Stockholders’ Equity-Shares of common stock issued for other than cash have been assigned amounts equivalent to the fair value of the service or assets received in exchange. Common stock share and per share amounts in these financial statements have been adjusted for the effects of a one for 101 reverse stock split that occurred in January 2016. 

Per Share Data-Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the year. Diluted loss per share is computed by dividing net loss by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to warrants, options and convertible instruments.

The Company has excluded all common equivalent shares outstanding for warrants, options and convertible instruments to purchase common stock from the calculation of diluted net loss per share because all such securities are anti-dilutive for the periods presented. As of June 30, 2019, the Company had outstanding 1,425,000 warrants and 67,879 options excluded from the calculation of diluted net loss; as of December 31, 2018, the Company had outstanding 1,167,653 warrants and 67,879 options excluded from the calculation of diluted net loss.

Income Taxes- The Company accounts for income taxes under the asset and liability method which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s condensed consolidated financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than possible enactments of changes in the tax laws or rates.

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses, the sale of profitable divisions and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance.  The following table reflects the deferred tax asset balance at June 30, 2019:

	June 30, 2019
Deferred tax Asset		718,332
Less: valuation allowance		(718,332	)
Net deferred tax asset		-

The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the condensed consolidated financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is generally no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012.

Business Combinations- The Company accounts for business combinations by recognizing the assets acquired, liabilities assumed, contractual contingencies, and contingent consideration at their fair values on the acquisition date. The purchase price allocation process requires management to make significant estimates and assumptions, especially with respect to intangible assets, estimated contingent consideration payments and pre-acquisition contingencies. Examples of critical estimates in valuing certain of the intangible assets we have acquired or may acquire in the future include but are not limited to:

● future expected cash flows from product sales, support agreements, consulting contracts, other customer contracts, and acquired developed technologies and patents; and

● discount rates utilized in valuation estimates.

Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results. Additionally, any change in the fair value of the acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, such as changes in our estimates of relevant revenue or other targets, will be recognized in earnings in the period of the estimated fair value change. A change in fair value of the acquisition-related contingent consideration or the occurrence of events that cause results to differ from our estimates or assumptions could have a material effect on the condensed consolidated financial position, statements of operations or cash flows in the period of the change in the estimate.

7

Impairment of Long-Lived Assets-Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed would be separately presented in the condensed consolidated balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and are no longer depreciated. The assets and liabilities of a disposal group classified as held-for-sale would be presented separately in the appropriate asset and liability sections of the condensed consolidated balance sheet, if material. No impairment losses have been realized for the periods presented.

Financial Instruments and Fair Values-The fair value of a financial instrument represents the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. Fair value estimates are made at a specific point in time, based upon relevant market information about the financial instrument. In determining fair value, we use various valuation methodologies and prioritize the use of observable inputs. We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:

Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable.

Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates.

Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability.

The use of observable and unobservable inputs and their significant in measuring fair value are reflected in our hierarchy assessment. The carrying amount of cash, prepaid assets, accounts payable and accrued liabilities approximates fair value due to the short-term maturities of these instruments. Because cash and cash equivalents are readily liquidated, management classifies these values as Level 1. The fair value of the debentures, approximate their book value as the instruments are short-term in nature and contain market rates of interest. Because there is no ready market or observable transactions, management classifies the debentures as Level 3.

Recently Issued Accounting Standards-There are various other updates recently issued, most of which represent technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s condensed consolidated financial position, results of operations or cash flows.

Note 3 – Financial Condition and Going Concern

As of June 30, 2019, the Company had cash of $284, current liabilities of $1,851,108, and has incurred a loss from operations. True Nature Holding’s principal operation is the development and deployment of software and systems for the healthcare marketplace. The Company develops solutions in a) healthcare records, b) the sale of applications in the health and wellness area from 3^rd parties in addition to its own developed products. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to execute its business plan.

As a result of these factors, there is substantial doubt about the ability of the Company to continue as a going concern. The Company’s continuance is dependent on raising capital and generating revenues sufficient to sustain operations. The Company believes that the necessary capital will be raised and has entered into discussions to do so with certain individuals and companies. However, as of the date of these condensed consolidated financial statements, no formal agreement exists.

The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions. 

Note 4 – Related Party Transactions

Six months ended June 30, 2019:

On March 11, 2019, the Company issued 100,000 shares of common stock to its President as compensation, and charged the fair value in the amount of $8,740 to operations.

On March 11, 2019, the Company issued 100,000 shares of common stock to a board member as compensation, and charged the fair value in the amount of $8,740 to operations.

8

During the six months ended June 30, 2019, the Company accrued the amount of $2,875 in connection with the vested portion of a common stock award granted to its President.

At June 30, 2019, the Company has the following amounts due to related parties:

● Due to shareholders for accounts payable paid on behalf of the Company and accrued interest: $50,099

● Note payable in the amount of $75,000 related to reclassification of accounts payable (see note 5, “July 2017 Note”)

● Note payable in the amount of $65,000 related to consulting services provided (see note 5, “Consulting Services Note”)

● Note payable in the amount of $58,000 related to accounts payable paid on behalf of the Company (see note 5, “Trade Payables Note”)

Six months ended June 30, 2018:

On January 29, 2018, the Company converted outstanding accounts payable due to an investor in the amount of $54,815 for 527,064 restricted shares of the Company’s common stock. The cost to the Company for this issuance is $54,815, based on the closing price on the date of issuance. As the conversion amount equals the share value, no gain or loss was recorded.

On January 29, 2018, the Company converted accrued officer compensation in the amount of $93,333 into 897,432 restricted shares of the Company’s common stock. The cost to the Company for this issuance is $93,333, based on the closing price on the date of issuance. As the conversion amount equals the share value, no gain or loss was recorded.

On April 23, 2018, the Company issued 600,000 shares of common stock with a value of $48,000 to an investor, and an additional 600,000 shares of common stock with a value of $48,000 to a not for profit entity at the request of the investor due to conversion of $96,000 of accounts payable, no gain or loss was recognized due to stock price matching the amount converted.

On April 23, 2018, the Company issued 500,000 shares of common stock to its President, subject to certain vesting conditions: (i) 100,000 shares vest when the President has been employed 90 days from the effective date of the employment agreement; (ii) 100,000 shares vest when the President has been employed one year from the effective date of the employment agreement; (iii) 100,000 shares vest when the President has been employed two years from the effective date of the employment agreement; (iv) 100,000 shares vest when the Company completes a capital raise of $2,000,000; (v) 100,000 shares vest when the Company reports $20,000,000 in gross revenue. The Company valued the shares at the fair market value of $0.10 per share, or a total value of $50,000. During the three months ended June 30, 2018, the total amount of $13,740 was charged to operations pursuant to the various vesting conditions.

On June 13, 2018, the Company issued 100,000 shares of common stock with a fair value of $8,380 to its President as a bonus.

On June 14, 2018, the Company issued 100,000 shares of common stock with a fair value of $9,000 to its chairman as a bonus. Also on June 14, 2018, the Company issued 100,000 shares of common stock with a fair value of $9,000 to a board member as a bonus.

On June 14, 2018, the Company issued to an investor 1,100,000 restricted shares of the Company’s common stock with a fair value of $95,700 for reimbursement of $60,000 of accrued expenses paid on behalf of the Company and for services provided. The Company recognized a loss on conversion of $35,700 due to share price exceeding the value of the stock granted.

The Company accrued officer’s compensation during the six months ended June 30, 2018 in the amount of $50,000 and imputed interest expense of $4,500 on a note payable to a related party in the amount of $75,000 (see note 5).

9

Note 5 – Debt

March 2016 Convertible Note A

On March 18, 2016, the Company issued a 12% Convertible Promissory Note (the “Convertible Note A”) in the principal amount of $60,000 to a lender. Upon issuance of the Convertible Note A, the lender was awarded 15,000 restricted common stock as an origination fee which includes piggy back registration rights. On September 19, 2016, the Company issued the lender an additional 15,000 restricted common stock at a price of $0.30 per share to extend the term of the loan agreement indefinitely. The cost to the Company was $4,050 in interest expense.  On August 10, 2017, the Company issued 25,000 shares of common stock with a fair value of $3,750 for accrued interest through August 1, 2017 in the amount of $7,860.  In April 2018, the Company issued 75,000 shares of common stock with a value of $7,500 as consideration for an extension of the term of the loan to July 1, 2018, and on August 13, 2018, the Company issued an additional 75,000 shares of common stock with a value of $6,750 for an extension of the term of the loan to October 31, 2018. During the six months ended June 30, 2019, the lender converted principal in the amount of $15,000 into 120,000 shares of common stock. The Company recorded a loss in the amount of $13,867 on this conversion. The Company accrued interest in the amount of $2,900 on this note during the six months ended June 30, 2019. At June 30, 2019, the principal amount of the March 2016 Convertible Note A was $45,000 and accrued interest was $4,379. 

Pursuant to the terms of the Convertible Note A, the Company is obligated to pay monthly installments of not less than $1,000 the first of each month commencing the month following the execution of the Convertible Note A until its maturity on September 16, 2016 at which time the Company is obligated to repay the full principal amount of the Convertible Note A. The Convertible Note A is convertible by the holder at any time into shares of the Company’s common stock at price of $1.00 per share, and throughout the duration of the note, the holder has the right to participate in any financing the Company may engage in upon the same terms and conditions as all other investors. The Company allocated the face value of the Convertible Note A to the shares and the note based on relative fair values, and the amount allocated to the shares of $18,750 was recorded as a discount against the note.

The beneficial conversion feature of $9,375 was recorded as a debt discount with an offsetting entry to additional paid-in capital decreasing the note payable and increasing debt discount. The debt discount is being amortized to interest expense over the term of the debt. For the year ended December 31, 2016, debt discount amortization related to the Convertible Note A was $28,125.  There was no amortization of the discount during the six months ended June 30, 2019.

August 2014 Convertible Debentures (Series C)

As part of the restructuring all debentures issued by Trunity Holdings, Inc., to fund the former, educational business were eligible to participate in a debt conversion; however, one debenture holder that was issued a Series C Convertible Debenture (the “Series C Debenture”) in August 2014 with an aggregate face value of $100,000 in exchange for the cancellation of Series B Convertible Debentures with a carrying value of $110,833 did not convert such debenture. The Series C Debenture accrues interest at an annual rate of 10%, matured November 2015, and is convertible into our common stock at a conversion rate of $20.20 per share. The holders of the Series C Debenture also received five-year warrants to acquire up to 4,950 shares post-split of common stock for an exercise price of $20.20 per share. The former educational business allocated the face value of the Series C Debenture to the warrants and the debentures based on its relative fair values, and allocated to the warrants, which was recorded as a discount against the Series C Debenture, with an offsetting entry to additional paid-in capital. The discount was fully expensed upon execution of the new debentures as debt extinguishment costs within discontinued operations. The Company accrued interest in the amount of $5,534 on this note during the six months ended June 30, 2019. As of June 30, 2019, and December 31, 2018, the carrying value of this Series C Debenture was $110,833 and accrued interest expense of $52,121 and $46,587, respectively. The Series C Debenture is currently in default.

November 2014 Convertible Debentures (Series D)

As part of the restructuring all debentures issued by Trunity Holdings, Inc., to fund the former, educational business were eligible to participate in a debt conversion; however, one debenture holder that was issued a Series D Convertible Debenture (the “Series D Debenture”) in November 2014 with an aggregate face value of $10,000 in exchange for the cancellation of Series B Convertible Debenture with a carrying value of $11,333 did not participate in the debt conversion restructuring. The Series D Debenture accrues interest at an annual rate of 12%, matured November 2015, and is convertible into our common stock at a conversion rate of $16.67 per share. The holders of the Series D Debenture also received five-year warrants to acquire up to 495 shares of common stock for an exercise price of $20.20 per share on a post-split basis. The former educational business allocated the face value of the Series D Debenture to the warrants and the debentures based on their relative fair values, and allocated to the warrants, which was recorded as a discount against the Series D Debenture, with an offsetting entry to additional paid-in capital. The discount was fully expensed upon execution of the new debentures as debt extinguishment costs within discontinued operations. The Company accrued interest in the amount of $679 on this note during the six months ended June 30, 2019. As of June 30, 2019, and December 31, 2018, the carrying value of the Series D Debenture was $11,333 and accrued interest was $6,340 and $5,661, respectively.   The Series D Debenture is currently in default.

10

Short Term Loan

As a result of the acquisition of P3 Compounding of Georgia, LLC (“P3”) the Company had a short-term convertible note with a loan agency in the principal amount of $52,000 for the purchase of future sales and credit card receivables of P3. Under the terms of the receivable purchase agreement, the Company purchased an advance of $50,000 plus $2,000 for origination costs with a 10.5% daily interest rate to be repaid over 160 days at a repayment amount of $451.75 per day. The origination fee and interest were recorded as debt discount on the date of issuance in the amount of $22,280 and $22,280 was amortized during the year ending December 31, 2016. During the six months ended June 30, 2019, principal in the amount of $74,104 was converted into 1,401,224 shares of common stock; a loss in the amount of $16,955 was recorded on this transaction. The principal balance due under this note was $0 at June 30, 2019.

July 2017 Note

On July 10, 2017, the Company negotiated the reclassification of $75,000 in accounts payable to a loan payable (the “July 2017 Note”).  The July 2017 Note is due no later than 90 days after the receipt of a minimum of $1,000,000 of funding. The July 2017 Note bears no interest; however, if it is not paid by the due date, interest will accrue at the rate of 12% per year. During the six months ended June 30, 2019, the Company imputed interest in the amount of $4,500 on the July 2017 Note.

July 2018 RU Promissory Note

On July 26, 2018, the Company entered into an agreement with Resources Unlimited NW LLC (“RU”) pursuant to which RU provides business development services to the Company for a period of six months. As compensation for these services, the Company issued RU 250,000 shares of common stock with a fair value of $20,000 and a six month note payable in the amount of $30,000 (the “RU Note”). The RU Note bears interest at the rate of 12% per year; principal and interest are due on January 26, 2019. During the six months ended June 30, 2019, the Company accrued interest in the amount of $1,776 on the July 2018 RU Promissory Note. During the six months ended June 30, 2019, the Company converted principal and accrued in the amounts of $30,000 and $3,344, respectively, into an aggregate of 400,000 shares of common stock; a loss in the amount of $2,637 was recorded on this transaction. The principal balance due under this note was $0 at June 30, 2019.

Power Up Note 1

On July 5, 2018, the Company entered into a Securities Purchase Agreement with Power Up Lending Group Ltd. (“Power Up”) pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 1”) in the aggregate principal amount of $38,000. The Power Up Note entitles the holder to 12% interest per annum and matures on April 15, 2019.  Under the Power Up Note 1, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 1 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 1, at a price equal to 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, but no lower than $0.00006 (fixed price floor), provided, however, that Power Up may not convert the Power Up Note 1 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. On January 1, 2019, the Power Up Note 1 became convertible, and the Company recorded a discount in connection with the beneficial conversion feature in the amount of $9,032; $9,032 of this amount was charged to interest expense during the six months ended June 30, 2019. If the Company prepays the Power Up Note 1 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 1, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 1, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 1; $2,077 of this amount was charged to interest during the year ended six months ended June 30, 2019. During the year ended December 31, 2018, the Company paid principal and accrued interest in the amount of $27,764 and $2,236, respectively, on the Power Up Note 1. The Company accrued interest in the amount of $58 on this note during the six months ended June 30, 2019. During the six months ended June 30, 2019, the Company paid the remaining principal and accrued interest in the amount of $10,236 and $58, respectively, along with a prepayment penalty in the amount of $16,072 on the Power Up Note 1; The principal balance due under this note was $0 at June 30, 2019.

11

Power Up Note 2 

On August 10, 2018, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 2”) in the aggregate principal amount of $33,000. The Power Up Note 2 entitles the holder to 12% interest per annum and matures on May 14, 2019. Under the Power Up Note 2, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 2 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 2, at a price equal to 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, but no lower than $0.00006 (fixed price floor), provided, however, that Power Up may not convert the Power Up Note 2 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. On February 5, 2019, the Power Up Note 2 became convertible; there was no discount associated with the conversion feature of Power Up Note 2. If the Company prepays the Power Up Note 2 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 2, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 2; $3,000 was amortized to interest expense during the six months ended June 30, 2019. During the six months ended June 30, 2019 the Company also recorded a discount to the Power Up Note 2 in the amount of $32,500 related to a beneficial conversion feature; this amount was charged to operations during the six months ended June 30, 2019.  During the six months ended June 30 2019, principal and accrued interest in the amount of $33,000 and $1,980, respectively, were converted into a total of 624,993 shares of the Company’s common stock. The Company recognized a loss in the amount of $34,101 on these conversions which was charged to operations during the six months ended June 30, 2019. The Company accrued interest in the amount of $418 on the Power Up Note 2 during the six months ended June 30, 2019. The principal balance due under this note was $0 at June 30, 2019.

Power Up Note 3

On September 18, 2018, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 3”) in the aggregate principal amount of $38,000. The Power Up Note 3 entitles the holder to 12% interest per annum and matures on June 30, 2019.  Under the Power Up Note 3, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 3 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 3, at a price equal to 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, but no lower than $0.00006 (fixed price floor), provided, however, that Power Up may not convert the Power Up Note 3 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. On March 17, 2019, the Power Up Note 3 became convertible, and the Company recorded a discount in connection with the beneficial conversion feature in the amount of $38,000; $38,000 of this amount was charged to interest expense during the six months ended June 30, 2019. If the Company prepays the Power Up Note 3 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 3, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 3, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 3; $3,000 was amortized to interest expense during the six months ended June 30, 2019. During the six months ended June 30, 2019, principal and accrued interest in the amount of $38,000 and $2,280, respectively, were converted into a total of 1,173,632 shares of the Company’s common stock. The Company recognized a loss in the amount of $45,724 on these conversions which was charged to operations during the six months ended June 30, 2019. The Company accrued interest in the amount of $1,592 on Power Up Note 3 during the six months ended June 30, 2019. The principal balance under this note was $0 at June 30, 2019.

12

Power Up Note 4

On November 9, 2018, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 4”) in the aggregate principal amount of $33,000. The Power Up Note 4 entitles the holder to 12% interest per annum and matures on August 31, 2019.  Under the Power Up Note 4, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 4 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 4, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 4 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. On May 8, 2019, the Power Up Note 4 became convertible, and the Company recorded a discount in connection with the beneficial conversion feature in the amount of $33,000; $33,000 of this amount was charged to interest expense during the six months ended June 30, 2019. If the Company prepays the Power Up Note 4 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 4, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 4, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 4; $3,000 was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest in the amount of $976 on Power Up Note 4 during the six months ended June 30, 2019. During the six months ended June 30, 2019, principal and accrued interest in the amount of $33,000 and $1,980, respectively, were converted into a total of 1,619,444 shares of the Company’s common stock. The Company recognized a loss in the amount of $63,443 on these conversions which was charged to operations during the six months ended June 30, 2019. The principal balance under this note was $0 at June 30, 2019.

 Auctus Note

On November 26, 2018, the Company entered into a Securities Purchase Agreement with Auctus Fund, LLC (“Auctus”) pursuant to which Auctus agreed to purchase a convertible promissory note (the “Auctus Note”) in the principal amount of $125,000. The Auctus Note entitles the holder to 12% interest per annum and matures on August 26, 2019.  Under the Auctus Note, Auctus may convert all or a portion of the outstanding principal of the Auctus Note into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Auctus Note, at a price equal to the higher of the variable conversion price or $0.00003 per share.  The variable conversion price shall mean 55% of the lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Auctus may not convert the Auctus Note to the extent that such conversion would result in beneficial ownership by Auctus and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Auctus Note within 90 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 135%; if such prepayment is made between the 91st day and the 180th day after the issuance of the Auctus Note, then such redemption premium is 150%. After the 180th day following the issuance of the Auctus Note, there shall be no further right of prepayment. In connection with the Auctus Note, the Company issued five year warrants to purchase 625,000 shares of the Company’s common stock at a price of $0.10 per share. The Company valued these warrants at $39,595, and recorded this amount as a discount to the Auctus Note; $26,251 of this amount was amortized to interest expense during the six months ended June 30, 2019. On May 25, 2019, the Auctus Note became convertible, and the Company recorded a discount in connection with the beneficial conversion feature in the amount of $125,000; $31,079 of this amount was charged to interest expense during the six months ended June 30, 2019. The Company also recorded an original issue discount in the amount of $13,500 in connection with the Auctus Note; $8,951 was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest in the amount of $7,393 on the Auctus Note during the six months ended June 30, 2019. During the six months ended June 30, 2019, principal and accrued interest in the amount of $23,209 and $8,301, respectively, were converted into a total of 1,000,000 shares of the Company’s common stock. The Company recognized a loss in the amount of $1,291 on these conversions which was charged to operations during the six months ended June 30, 2019. The principal balance under this note was $101,791 at June 30, 2019.

13

Crown Bridge Note 1

On December 19, 2018, the Company entered into a Securities Purchase Agreement with Crown Bridge Partners, LLC (“Crown Bridge”) pursuant to which Crown Bridge agreed to purchase a convertible promissory note (the “Crown Bridge Note 1”) in the principal amount of $40,000. The Crown Bridge Note 1 entitles the holder to 12% interest per annum and matures on September 19, 2019.  Under the Crown Bridge Note 1, Crown Bridge may convert all or a portion of the outstanding principal of the Crown Bridge Note 1 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Crown Bridge Note 1, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 55% of the lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Crown Bridge may not convert the Crown Bridge Note 1 to the extent that such conversion would result in beneficial ownership by Crown Bridge and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Crown Bridge Note 1 within 90 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 135%; if such prepayment is made between the 91st day and the 180th day after the issuance of the Crown Bridge Note 1, then such redemption premium is 150%. After the 180th day following the issuance of the Crown Bridge Note 1, there shall be no further right of prepayment. In connection with the Crown Bridge Note 1, the Company issued five year warrants to purchase 400,000 shares of the Company’s common stock at a price of $0.10 per share. The Company valued these warrants at $34,500, and recorded this amount as a discount to the Crown Bridge Note 1; $22,790 of this amount was amortized to interest expense during the three months ended June 30, 2019. On June 17, 2019, the Crown Bridge Note 1 became convertible, and the Company recorded a discount in connection with the beneficial conversion feature in the amount of $40,000; $17,961 of this amount was charged to interest expense during the six months ended June 30, 2019. The Company also recorded an original issue discount in the amount of $5,500 in connection with the Crown Bridge Note 1; $3,634 was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest in the amount of $2,381 on the Crown Bridge Note 1 during the six months ended June 30, 2019. During the six months ended June 30, 2019, principal in the amount of $9,598 was converted into a total of 340,000 shares of the Company’s common stock. The Company recognized a loss in the amount of $2,881 on this conversion which was charged to operations during the six months ended June 30, 2019. The principal balance under this note was $30,402 at June 30, 2019.

Consulting Services Note

On December 31, 2018, the Company entered into a note payable agreement with an investor for consulting services performed on behalf of the Company in the amount of $65,000 (the “Consulting Services Note”). The Consulting Services Note matures on March 21, 2020, and bears interest at the rate of 12% per annum. The Company recorded $3,868 in interest on the Consulting Services Note during the six months ended June 30, 2019. The principal balance under this note was $65,000 at June 30, 2019.

Trade Payables Note

On December 31, 2018, the Company entered into a note payable agreement with an investor for payments of trade accounts payable made by the investor on behalf of the Company in the amount of $58,000 (the “Trade Payables Note”). The Trade Payables Note matures on March 21, 2020, and bears interest at the rate of 12% per annum. The Company recorded $3,451 in interest on the Consulting Services Note during the six months ended June 30, 2019. The principal balance under this note was $58,000 at June 30, 2019.

Power Up Note 5

On January 2, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 5”) in the aggregate principal amount of $53,000. The Power Up Note 5 entitles the holder to 12% interest per annum and matures on October 31, 2019.  Under the Power Up Note 5, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 5 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 5, at a price equal to the higher of the variable conversion price or $0.00006 per share. The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 5 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 5 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 5, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 5, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 5; $2,238 was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest in the amount of $3,119 on the Power Up Note 5 during the six months ended June 30, 2019. The principal balance under this note was $53,000 at June 30, 2019.

14

Power Up Note 6

On February 11, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 6”) in the aggregate principal amount of $48,000. The Power Up Note 6 entitles the holder to 12% interest per annum and matures on November 30, 2019.  Under the Power Up Note 6, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 6 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 6, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 6 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 6 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 6, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 6, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 6; $1,598 was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest on the Power Up Note 6 in the amount of $1,598 during the six months ended June 30, 2019. The principal balance under this note was $48,000 at June 30, 2019.

Crown Bridge Note 2

On March 4, 2019, the Company entered into a Securities Purchase Agreement with Crown Bridge Partners, LLC (“Crown Bridge”) pursuant to which Crown Bridge agreed to purchase a convertible promissory note (the “Crown Bridge Note 2”) in the principal amount of $40,000. The Crown Bridge Note 2 entitles the holder to 12% interest per annum and matures on December 4, 2019.  Under the Crown Bridge Note 2, Crown Bridge may convert all or a portion of the outstanding principal of the Crown Bridge Note 2 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Crown Bridge Note 2, at a price equal to the higher of the variable conversion price or $0.00003 per share.  The variable conversion price  shall mean 55% of the lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Crown Bridge may not convert the Crown Bridge Note 2 to the extent that such conversion would result in beneficial ownership by Crown Bridge and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Crown Bridge Note 2 within 90 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 135%; if such prepayment is made between the 91st day and the 180th day after the issuance of the Crown Bridge Note 2, then such redemption premium is 150%. After the 180th day following the issuance of the Crown Bridge Note 2, there shall be no further right of prepayment. In connection with the Crown Bridge Note 2, the Company issued five year warrants to purchase 400,000 shares of the Company’s common stock at a price of $0.10 per share. The Company valued these warrants at $34,500, and recorded this amount as a discount to the Crown Bridge Note 2; $14,803 of this amount was amortized to interest expense during the six months ended June 30, 2019. The Company also recorded an original issue discount in the amount of $5,500 in connection with the Crown Bridge Note 2; $2,360 of this amount was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest expense in the amount of $2,761 on the Crown Bridge Note 2 during the six months ended June 30, 2019. The principal balance under this note was $40,000 at June 30, 2019.

15

Power Up Note 7

On March 18, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 7”) in the aggregate principal amount of $43,000. The Power Up Note 7 entitles the holder to 12% interest per annum and matures on January 30, 2020.  Under the Power Up Note 7, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 7 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 7, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 7 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 7 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 7, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 7, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 7; $981 was amortized to interest expense during the six months needed June 30, 2019. The Company accrued interest in the amount of $1,456 on the Power Up Note 7 during the six months ended June 30, 2019. The principal balance under this note was $43,000 at June 30, 2019.

Power Up Note 8

On April 1, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 8”) in the aggregate principal amount of $53,000. The Power Up Note 8 entitles the holder to 12% interest per annum and matures on January 30, 2020.  Under the Power Up Note 8, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 8 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 8, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 8 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 8 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 8, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 8, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 8; $883 was amortized to interest expense during the six months needed June 30, 2019. The Company accrued interest in the amount of $1,586 on the Power Up Note 8 during the six months ended June 30, 2019. The principal balance under this note was $53,000 at June 30, 2019.

Power Up Note 9

On May 2, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 9”) in the aggregate principal amount of $33,000. The Power Up Note 9 entitles the holder to 12% interest per annum and matures on February 28, 2020.  Under the Power Up Note 9, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 9 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 9, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 9 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 9 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 9, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 9, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 9; $594 was amortized to interest expense during the six months needed June 30, 2019. The Company accrued interest in the amount of $662 on the Power Up Note 9 during the six months ended June 30, 2019. The principal balance under this note was $33,000 at June 30, 2019.

16

BHP Note

On June 4, 2019, the Company entered into a securities purchase agreement with BHP Capital NY, Inc., a New York corporation (“BHP”), pursuant to which BHP agreed to purchase a Convertible Promissory Note (the “BHP Note”) in the principal amount of $38,500.   The BHP Note the holder to 10% interest per annum and matures on March 4, 2020.  In the event the Company prepays the BHP Note beginning on the issuance date through the 180th day following the issuance date, the Company must pay BHP all of the outstanding principal and interest due plus a cash redemption premium ranging from 135% to 150%. After the 180th day following the issuance date, there is no further right of prepayment by the Company. BHP has no right of conversion under the BHP Note for a period of 180 days commencing on the issuance date. In the event the Company has not paid the BHP Note in full prior to 180 days from the issuance date, BHP may convert all or a portion of the outstanding principal of the BHP Note into shares of the Company’s common stock at a price per share at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price shall mean 55% of the lowest traded price of the Common Stock during the 25 trading day period ending on the last complete trading day prior to the date of conversion. BHP may not convert the BHP Note to the extent that such conversion would result in beneficial ownership by BHP and its affiliates of more than 4.99% of the issued and outstanding Common Stock. The BHP Note contains certain representations, warranties, covenants and events of default including if the Common Stock is suspended or delisted for trading on the OTC Marketplace or if the Company is delinquent in its periodic report filings with the SEC. In the event of default, as described in the BHP Note, at the option of BHP, it may consider the BHP Note immediately due and payable. The Company recorded an original issue discount in the amount of $3,000 in connection with the BHP Note; $522 was amortized to interest expense during the six months needed June 30, 2019. The Company accrued interest in the amount of $329 on the BHP Note during the six months ended June 30, 2019. The principal balance under this note was $38,500 at June 30, 2019.

Armada Note

On June 10, 2019, the Company entered into a securities purchase agreement with Armada Investment Fund, LLC (“Armada”) pursuant to which Armada agreed to purchase a convertible promissory note (the “Armada Note”) in the aggregate principal amount of $38,500. The Armada Note the holder to 10% interest per annum and matures on March 10, 2020.  In the event the Company prepays the Armada Note beginning on the issuance date through the 180th day following the Armada Issuance Date, the Company must pay Armada all of the outstanding principal and interest due plus a cash redemption premium ranging from 135% to 150%. After the 180th day following the Armada Issuance Date, there is no further right of prepayment by the Company. Armada has no right of conversion under the Armada Note for a period of 180 days commencing on the Armada Issuance Date. In the event the Company has not paid the Armada Note in full prior to 180 days from the Armada Issuance Date, Armada may convert all or a portion of the outstanding principal of the Armada Note into shares of the Company’s common stock at a price per share equal to the higher of the variable conversion price or $0.00006 per share. The variable conversion price shall mean 55% of the lowest traded price of the Common Stock during the 25 trading day period ending on the last complete trading day prior to the date of conversion. Armada may not convert the Armada Note to the extent that such conversion would result in beneficial ownership by Armada and its affiliates of more than 4.99% of the issued and outstanding Common Stock. The Armada Note contains certain representations, warranties, covenants and events of default including if the Common Stock is suspended or delisted for trading on the OTC Marketplace or if the Company is delinquent in its periodic report filings with the SEC. In the event of default, as described in the Armada Note, at the option of Armada, it may consider the Armada Note immediately due and payable. The Company recorded an original issue discount in the amount of $3,000 in connection with the Armada Note; $255 was amortized to interest expense during the six months needed June 30, 2019. The Company accrued interest in the amount of $253 on the Armada Note during the six months ended June 30, 2019. The principal balance under this note was $38,500 at June 30, 2019.

Note 6 – Stockholders’ Deficit

Shares for Stock Based Compensation

During the six months ending June 30, 2019, the Company issued 200,000 restricted shares of the Company’s common stock at valued $17,480 in exchange for services conducted on behalf of the Company. The value of these shares was based on the closing market price on the respective date of grant.  Also during the six months ended June 30, 2019, the Company issued 1,000,000 shares of common stock to employees, subject to vesting provisions, pursuant to employment agreements. The par value of these shares in the amount of $10,000 was credited to paid-in capital. During the six months ended June 30, 2019, the Company charged the amount of $25,093 to paid-in capital representing the vesting of shares issued to employees. 

17

During the six months ending June 30, 2018, the Company issued 800,000 restricted shares of the Company’s common stock at valued $40,120 in exchange for reimbursement of expenses paid on behalf of the Company and for services provided. The value of these shares was based on the closing market price on the respective date of grant.

Stock-based compensation expenses are included in general and administrative expenses on the condensed consolidated statements of operations.

Shares issued for notes payable

During the six months ended June 30, 2019, the Company issued, in 13 transactions, a total of 5,278,069 shares in connection with the conversion of notes payable principal and accrued interest in the aggregate amount of $177,365 and $19,385, respectively; a loss in the aggregate amount of $158,659 was recognized on these transactions (see note 5).

During the six months ending June 30, 2018, the Company issued 75,000 restricted shares of common stock valued at $7,500 for an extension of the term of a note payable.  

Shares issued for conversion of accounts payable

During the six months ended June 30, 2019, the Company did not issue any shares to settle accounts payable.

During the six months ending June 30, 2018, the Company issued 4,405,123 shares valued at $432,733 to settle outstanding accounts payable.  There was a loss on the transaction of $36,100 because the fair value of the issuance exceeded the fair value of the accounts payable settled.

Stock returned for cancellation

During the six months ended June 30, 2019, the Company cancelled 400,000 shares of common stock issued to a former executive officer.

During the six months ended June, 2018. there were no cancellations of common stock.

Shares issued for legal settlement

During the six months ended June 30, 2019, the Company issued 1,401,224 shares of common stock in connection with the settlement of a note payable in the amount of $74,104. The Company recorded a loss in the amount of $26,924 in connection with this transaction.

During the six months ended June, 2018. there were no shares issued in connection with a legal settlement.

18

Note 7 – Stock Options

A summary of options issued, exercised and cancelled are as follows:

	Shares		Weighted- Average Exercise Price ($)		Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value ($)
Outstanding at December 31, 2017		67,879	$	21.40		5.17	$	-
Granted		-		-		-		-
Cancelled		-		-		-		-
Outstanding at December 31, 2018		67,879	$	21.40		4.17		-
Granted		-		-		-		-
Cancelled		-		-		-		-
Outstanding at June 30, 2019		67,879	$	21.40		3.67	$	-
Exercisable at June 30, 2019		67,879	$	21.40		3.67	$	-

Note 8 – Stock Warrants

A summary of warrants issued, exercised and expired are as follows:

	Shares			Weighted- Average Exercise Price ($)		Weighted- Average Remaining Contractual Term
Outstanding at December 31, 2017		142,653		$	17.42		1.00
Granted		1,025,000			0.10		4.93
Expired		-			-		-
Outstanding at December 31, 2018		1,167,653		$	2.18		4.36
Granted		400,000			0.10		4.50
Expired		(142,653	)		17.42		-
Outstanding at June 30, 2019		1,425,000		$	0.10		4.50
Exercisable at June 30, 2019		1,425,000		$	0.10		4.50

19

Note 9 – Commitments and Contingencies

Legal

Stress Free Capital, Inc. vs. True Nature Holdings, Inc. Case No. CACE-18-0108656

Pursuant to a judgment rendered in the Seventeenth Judicial District I and for Broward County, Florida, the Company in June 2019 issued 1,401,224 shares of common stock in complete settlement of a note payable to the plaintiff in the aggregate amount of $84,073.48.

National Council for Science and the Environment, Inc. v. Trunity Holdings, Inc., Case No. 2015 CA 009726 B, Superior Court for the District of Columbia, Civil Division.

This action was filed on December 16, 2015 by the National Council for Science and the Environment, Inc. (“NCSE”) in the state court in the District of Columbia against Trunity Holdings, Inc. (“Trunity”) and alleges claims for breach of contract. Acknowledgement of indebtedness and settlement agreement and quantum meruit arising out of an agreement entered into between NCSE and Trunity in 2014. The complaint seeks damages in the amount of $177,270, inclusive of attorney’s fees, costs and accrued interest, continuing interest in the amount of 12% per annum and attorney’s fees and costs of collection relating to the case. The Company, in its answer dated January 27, 2016, denied the material allegations made by NCSE, asserted a number of affirmative defenses and filed a counterclaim alleging claims for fraud, negligent misrepresentation, breach of fiduciary duty, breach of contract and unjust enrichment. In its counterclaim, the Company sought actual and compensatory damages against NCSE that it believes exceed the amount sought by NCSE on its claims, pre-judgment interest, punitive damages and all costs and expenses, including attorney’s fees, incurred by the Company in bringing its claims against NCSE.

On September 23, 2016, the Company settled this obligation with an agreement to pay $48,500 to NCSE if paid by November 4, 2016, and $75,000 if paid later. The Company has not paid the amounts as of the date of this filing and has recorded the obligation at $75,000.

Carlton Fields Jorden Burt, P.A.

This action was filed on May 18, 2017 by a law firm that represented the Company prior to the spin-out of the educational software business in 2016 with the intent of collection past due invoices in the aggregate amount of $241,828.  The Company believes it has strong defenses against any such action and anticipates a settlement upon completion of certain funding activities. The Company has recorded a liability in the amount of $241,828 on its balance sheet at December 31, 2018. The Company has negotiated a settlement to this claim subject to funding.

Trunity, Inc.

The spin-out that now owns the former educational software business has been informed that they owe the Company from the obligations of the NCSE settlement, and the costs of the legal action. We intend to take all actions available to us to collect on these amounts.

Randstad General Partner (US) LLC D/B/A Tatum

A former service provider of the Company has filed an action in Georgia to collect the amount of $44,365 for services provided to the Company. On October 18, 2018, the Superior Court of Fulton County, State of George issued an Order & Final Judgment against the Company in the amount of $44,365 plus an additional $11,001 of accrued interest. The Company has accrued the amount of $55,366 on its balance sheet at June 30, 2019 in connection with this claim. On July 3, 2019 the Company settled this matter with a $5,000 payment made by a shareholder for the benefit of the Company.

20

Note 10 – Subsequent Events

In July 2019, the Company received funds of approximately $36,000 pursuant to Crown Bridge Note 3. Crown Bridge Note 3 is a convertible promissory note in the amount of $40,000 with an original issue discount of $4,000. Crown Bridge Note 3 bears interest at the rate of 12% per year and becomes convertible at any time following the 180^th calendar day after the issue date at a price per share equal to 55% of the lowest trading price for the Company’s common stock for the twenty-five days prior to the conversion date. The Crown Bridge Note 3 is due April 2, 2020.

In July 2019, the Company received funds of approximately $35,000 pursuant to Power Up Note 10. Power Up Note 10 is a convertible promissory note in the amount of $38,000 with an original issue discount of $3,000. Power Up Note 10 bears interest at the rate of 12% per year and becomes convertible at any time following the 180^th calendar day after the issue date at a price per share equal to 55% of the lowest trading price for the Company’s common stock for the twenty-five days prior to the conversion date.  The Power Up Note 10  is due April 30, 2020.

In July 2019, the Company issued 377,834 shares of common stock in connection with the conversion of $15,000 of principle due under the Power Up Note 5.

In July 2019, the Company issued 523,560 shares of common stock in connection with the conversion of $20,000 of principle due under the Power Up Note 5.

In July 2019, the Company issued 586,704 shares of common stock in connection with the conversion of $18,000 of principle due under the Power Up Note 5.

In July 2019, the Company issued 360,000 shares of common stock in connection with the conversion of $10,197 of principle due under the Crown Bridge Note 1.

In July 2019, the Company cancelled 300,000 shares of common stock held by its previous Chief Executive Officer.

In August 2019, the Company issued 1,000,000 shares of common stock in connection with the conversion of $29,050 of principal due under the Auctus Note.

21

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited consolidated financial statements and the related notes thereto contained in Part I, Item 1 of this Quarterly Report on Form 10-Q (this “Quarterly Report”). Our condensed consolidated financial statements have been prepared and, unless otherwise stated, the information derived therefrom as presented in this discussion and analysis is presented, in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

The information contained in this Quarterly Report is not a complete description of our business or the risks associated with an investment in our common stock. We urge you to carefully review and consider the various disclosures made by us in this Quarterly Report and in our other reports filed with the U.S. Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and subsequent reports on Form 8-K, which discuss our business in greater detail. Unless the context indicates otherwise, the “Company”, “we”, “us”, and “our” in this Item 2 and elsewhere in this Quarterly Report refer to True Nature Holdings, Inc., a Delaware corporation, and its consolidated subsidiaries.

In addition to historical information, the following discussion contains forward-looking statements regarding future events and our future performance. In some cases, you can identify forward-looking statements by terminology such as “will”, “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “forecasts”, “potential” or “continue” or the negative of these terms or other comparable terminology. All statements made in this Quarterly Report other than statements of historical fact are forward-looking statements. These forward-looking statements involve risks and uncertainties and reflect only our current views, expectations and assumptions with respect to future events and our future performance. If risks or uncertainties materialize or assumptions prove incorrect, actual results or events could differ materially from those expressed or implied by such forward-looking statements. Risks that could cause actual results to differ from those expressed or implied by the forward-looking statements we make include, among others, risks related to: our ability to successfully implement our business plan, develop and commercialize our software in a timely manner or at all, identify and acquire additional software products, manage our operations, service our debt, obtain financing necessary to operate our business, recruit and retain qualified personnel, manage any growth we may experience and successfully realize the benefits of our acquisitions and collaborative arrangements we may pursue; outsourcing facilities and pharmacies; general economic and business conditions; regulatory and legal risks and uncertainties related to our operations and the business in general; our limited operating history; and the other risks and uncertainties described under the heading “Risk Factors” in Item 1A of our Annual Report on Form 10-K and any other reports we file with the SEC. You should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made and, except as required by law, we undertake no obligation to revise or publicly update any forward-looking statement for any reason.

Company Overview

Our business during 2019 is focused in the area of software and solutions, predominantly in the healthcare sector, generally described as the healthcare information and technology (HCIT) market, although we are considering other software oriented solutions where providing the user compliance with industry specific regulatory compliance is a value. We announced plans for a personal healthcare records (PHR) application, SimpleHIPAA, which will allow individuals to track their personal healthcare information. This type of application is intended to include information from the individual, as well as data from healthcare providers extracted from their electronic healthcare records (EHR) systems. Data from individuals might include manual input or from personal devices such as watches, activity trackers and diagnostic devices such as glucose meters or blood pressure measuring devices. Information from healthcare providers might include data gathered from regular doctor visits, specialized care, or even a simple as prescription information from a pharmacy. We are also considering compliance oriented solutions in the financial area, and where a point of sale application may have application.

Our initial implementation of “SimpleHIPAA”, and “SimpleHIPAA for Vets and Pets”, is intended to include data from pharmacy and prescribers, generated at the time a prescription is written. This information will be embedded inside the application and made available to the end user from both the healthcare provider and from the pharmacy. While providing a starting point for tracking healthcare information for the end user, it also establishes a communications method between the end user and the healthcare provider, and the pharmacy. This communications channel, often thought of as “telemedicine” can allow the end user to provide feedback to the healthcare provider, the pharmacy, or other parties of the end user’s choice.

22

We have established a design that allows the same product to be used for both human and pet situations, and in a simple form. Further, recognizing that controlling costs is an issue in healthcare, we are providing for advertising to be included in the design. This should both mitigate the costs to deploy the solution for all parties, and also perhaps incentivize the end user to stay engaged with the application long term for the coupons, points or other benefits that advertising participants might provide.

Our strategy is to deploy SimpleHIPAA and SimpleHIPAA for Vets and Pets using a “top down” distribution through suppliers of healthcare materials who might provide the application to pharmacy and healthcare providers as a means of selling their products more efficiently, and with a “bottom up” approach, letting the end user download and use the application with data already embedded from their healthcare provider or pharmacy.

The initial development began in mid-2018, and it is currently awaiting the completion of testing at its first site, a pharmacy in south Florida with a 15-year history in both human and veterinary services. We have also explored the development of a next generation pharmacy management system that would embrace tools for compliance with new regulatory requirements in the pharmacy industry and expect to have a final decision on that project by mid-2019.

While this project continues, we are also evaluating other applications, generally, but not exclusively in the healthcare area. We believe that new technologies such as voice recognition, virtual reality and robotics will all provide excellent vehicles to update traditional information management systems and will find quick acceptance in the healthcare field as well as other large and more traditional markets.

Within the healthcare arena one of the most active areas involves software that provides “interoperability”, the interfacing of systems and data so that information may be shared effectively. We believe there will be many opportunities in this application area, as older systems are integrated with newer, or more specialized systems, but we have not taken any actions in pursuit of these opportunities and no guarantee can be made if we enter this space, that we will be successful. We believe that similar opportunities existing in many other non-healthcare applications and will continue to explore those as near term potential business areas.

Off-Balance Sheet Arrangements

Since our inception, except for standard operating leases, we have not engaged in any off-balance sheet arrangements, including the use of structured finance, special purpose entities or variable interest entities. We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

Critical Accounting Policies

For the six months ended June 30, 2019, there were no significant changes to our critical accounting policies and estimates from those disclosed in the section “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018.

Recently Issued and Adopted Accounting Pronouncements

See Note 2 to our consolidated financial statements included in this Quarterly Report.

Results of Operations

The following period-to-period comparisons of our financial results are not necessarily indicative of results for the current period or any future period. Our software, systems and consulting operations activities have become our primary focus, along with engagement with our new and potential user base. This change our operations will have and is expected to continue to have a significant impact on our financial results.

For the Three Months ended June 30, 2019 and 2018

Our total operating expenses for the three months period ended June 30, 2019 were $226,250.  For the comparable period in 2018, the operating expense was $276,026.  Operating expenses were comprised primarily of $103,984 in consulting fees, $40,105 in financial services and audit fees, $28,688 in compensation, $19,854 in travel, and $14,480 of insurance costs.

23

There was $164,504 of interest expense for the three months ended June 30, 2019, compared to $9,505 for the comparable period of 2018. Interest expense consisted of $138,101 in amortization of the discount on convertible debt; $20,473 of accrued interest; $3,680 of accrued interest to related parties, and $2,250 of interest imputed on related party debt.

The Company had a loss on conversion of accounts payable of $0 during the three months ended June 30, 2019, compared to a loss on conversion of accounts payable of $36,100 during the comparable period of 2018.

The Company had a loss on legal settlement in the amount of $26,924 during the three months ended June 30, 2019; there was no such transaction during the comparable period of 2018.

The Company had a loss on conversion of notes payable $58,935 during the three months ended June 30, 2019, compared to a loss on conversion of notes payable of $0 during the comparable period of 2018.

For the reasons above, the Company had a loss in the amount of $476,613 during the three months ended June 30, 2019, compared to a loss in the amount of $321,631 during the three months ended June 30, 2018.

For the Six Months ended June 30, 2019 and 2018

Our total operating expenses for the six months period ended June 30, 2019 were $447,501.  For the comparable period in 2018, the operating expense was $329,305.  Operating expenses were comprised primarily of compensation expense of $128,211, consulting fees of $148,936, financial services, legal, and audit fees of $83,090, travel of $29,247, and insurance of $26,570.

There was $324,901 of interest expense for the six months ended June 30, 2019, consisting of $261,035 of amortization of the discount on convertible debt, $37,475 of accrued interest, $4,500 of interest imputed on related party debt, $16,072 of prepayment penalties on notes payable, and $7,319 of interest accrued on related party debt. For the comparable period of 2018, the Company had interest expense of $16,666.

The Company had a loss on conversion of accounts payable of $0 during the six months ended June 30, 2019, compared to a loss on conversion of accounts payable of $36,100 during the comparable period of 2018. 

The Company had a loss on legal settlement in the amount of $26,924 during the six months ended June 30, 2019; there was on such transaction during the comparable period of 2018.

The Company had a loss on conversion of notes payable $158,659 during the six months ended June 30, 2019, compared to a loss on conversion of notes payable of $0 during the comparable period of 2018. 

For the reasons above, the Company had a loss in the amount of $957,985 during the six months ended June 30, 2019, compared to a loss in the amount of $382,071 during the six months ended June 30, 2018.

Liquidity and Capital Resources

We have financed our operations through the sale of equity securities. As of June 30, 2019, we had a working capital deficit of $1,850,824.  Our working capital deficit is attributable to the fact that we have been implementing the Company’s business plan of development of software, and acquisition of various software and systems businesses.

During the six months ending June 30, 2019, the Company had net cash used in operating activities of $304,342.  This consisted of Company’s net loss of $957,985, offset by a loss on conversion of notes payable of $158,659, loss on legal settlement of $26,924, imputed interest expense of $4,500, amortization of the discount on notes payable of $261,035, stock-based compensation in the amount of $42,573, and the net change in the components of working capital in the net amount of $159,952.  The Company had cash provided by financing activities in the amount of $307,764 which consisted of the proceeds of notes payable in the amount of $313,558, less principal payments in the amount of $10,236. There was no cash provided by investing activities during the six months ended June 30, 2019. The following securities are currently in default: the Company’s Series C Debenture, in the principal and accrued interest amounts of $110,833 and $52,121, respectively; and the November 2014 Convertible Debenture (Series D), in the principal and accrued interest amounts of $11,333 and $6,340, respectively.

24

Plan of Operations

We are actively developing our current SimpleHIPAA and SimpleHIPAA for Vets and Pets products and awaiting completion of testing before beginning a targeted marketing plan. We are also in discussions to acquire a number of existing software and systems businesses, generally aimed at heath care information technology (HCIT). Our staff now includes executives with relationships and a history of business with major market participants including Microsoft, Amazon, Apple and IBM. We expect to be able to grow our business activities through sales and marketing to and with those major players in the industry as well as others worldwide.

Recent Developments 

Appointments to the Board

On May 22, 2019, the Company’s Board of Directors appointed Mr. Douglas Cole as a member of the Board, effective immediately. Mr. Cole (Doug), age 63, has served as the Chairman and CEO of American Battery Metals Corporation since August 2017. Doug has been a Partner with Objective Equity LLC since 2005, a boutique investment bank focused on the high technology, data analytics and the mining sector. Doug serves on the Board of Directors of eWellness Healthcare Corporation (OTC:EWLL). Since 1977 Mr. Cole has held various executive roles, including Chairman, Executive Vice Chairman, Chief Executive Officer and President of multiple public corporations. Currently, Doug sits on the Board of "People in Motion," a global data analytics company. He also sits on the Board of "Voise," an AI company specializing in linguistics. From 2000 to September 2005, he was the Director of Lair of the Bear, The University of California Alumni Family Camp located in Pinecrest, California. During the period between 1991 and 1996 he was the CEO of HealthSoft and he founded and operated Great Bear Technology, a global media company, which acquired Sony Image Soft and Starpress, then went public and eventually sold to Graphix Zone. In 1995, Doug was honored by NEA, a leading venture capital firm, as CEO of the year. In 1997 Doug became CEO of NetAmerica until merging in 1999. Since 1982 he has been very active with the University of California, Berkeley, mentoring early-stage technology companies.

Acquisition of Businesses and Financing

The Company has since 2017 developed plans for software, systems and consulting aimed at business development in the healthcare field. It has also invested significant time and effort in evaluating the use of telemedicine and kiosks for the delivery of health services into rural and other underserved markets. Lastly, it has individuals working full time on the design of telemedicine applications, with initial introduction into the veterinary markets, and into the human markets using the same software currently scheduled for Q4 of 2019. During the first quarter of 2019 we expanded our potential markets to include anywhere the ability to provide regulatory compliance is a valuable feature of the software solution, not unlike the needs in healthcare for HIPAA compliance and data security.

While it is busy on internal operations, it still reviews various acquisition opportunities and intends to target businesses who have a) strong regulatory compliance history, b) a record of profitable operations, c) potential developers of technology or consulting, or d) where the combination of technology and operations, facilitates cross selling of a growing line of products or expedited implementation.

On June 13, 2019, the Company executed a Non-Binding Letter of Intent (“EPOS LOI”) for the potential acquisition of Power EPOS Limited, a U.K. based provider of certain software and systems to the hospitality industry (doing business as PowerEPOS) (“EPOS”). Under the terms of the EPOS LOI, the Company shall, at its option, purchase all of the issued and outstanding shareholder interests of EPOS, or its assets, in exchange for a combination of (i) shares of a newly issued non-convertible Series A Preferred (the “Series A”), which will be redeemable in 36 months and pay interest at a rate of ten percent (10%) per annum; and (ii) Common Stock equal to twenty percent (20%) of the outstanding shares of Common Stock of the Company, subsequent to closing (the “EPOS Acquisition”). The Company has begun a review of accounting and is preparing for an audit as a part of its due diligence process. There is no assurance that the EPOS Acquisition will be effectuated.

25

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not required for a Smaller Reporting Company.
 

ITEM 4.  CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report (the "Evaluation Date"), we carried out an evaluation regarding the six months ended June 30, 2019, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer who is also serving as our Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Based upon this evaluation, our management concluded that, as of the Evaluation Date, our disclosure controls and procedures were not effective to provide reasonable assurance that information required to be disclosed in the reports that are filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified by the SEC's rules and forms and that our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.  Management believes the Company's disclosure controls and procedures are not effective because of the small size of the Company's accounting staff which may prevent adequate controls, such as segregation of duties, which is due to the cost/benefit associated with such remediation. To address the material weaknesses, the Company performed additional analysis and other procedures in an effort to ensure our condensed consolidated financial statements included in this Quarterly Report have been prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report on Form 10-Q fairly present in all material respects our financial condition, results of operations and cash flows for the periods presented.

Limitations on Internal Controls

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that the Company’s disclosure controls and procedures will detect or uncover every situation involving the failure of persons within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports. 

Changes in Internal Control Over Financial Reporting

The Company’s management is also responsible for establishing and maintaining adequate internal control over financial reporting to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. As of the Evaluation Date, no changes in the Company’s internal control over financial reporting occurred that have materially affected or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

During the six months ended June 30, 2019, there were no changes that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

26

PART II – OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS.

National Council for Science and the Environment, Inc. v. Trunity Holdings, Inc., Case No. 2015 CA 009726 B, Superior Court for the District of Columbia, Civil Division.

This action was filed on December 16, 2015 by the National Council for Science and the Environment, Inc. (“NCSE”) in the state court in the District of Columbia against Trunity Holdings, Inc. (“Trunity”) and alleges claims for breach of contract. Acknowledgement of indebtedness and settlement agreement and quantum meruit arising out of an agreement entered into between NCSE and Trunity in 2014. The complaint seeks damages in the amount of $177,270, inclusive of attorney’s fees, costs and accrued interest, continuing interest in the amount of 12% per annum and attorney’s fees and costs of collection relating to the case. The Company, in its answer dated January 27, 2016, denied the material allegations made by NCSE, asserted a number of affirmative defenses and filed a counterclaim alleging claims for fraud, negligent misrepresentation, breach of fiduciary duty, breach of contract and unjust enrichment. In its counterclaim, the Company sought actual and compensatory damages against NCSE that it believes exceed the amount sought by NCSE on its claims, pre-judgment interest, punitive damages and all costs and expenses, including attorney’s fees, incurred by the Company in bringing its claims against NCSE.

On September 23, 2016, the Company settled this obligation with an agreement to pay $48,500 to NCSE if paid by November 4, 2016, and $75,000 if paid later. The Company has not paid the amounts as of the date of this filing and has recorded the obligation at $75,000.

On April 5, 2017, NCSE filed a petition to domesticate a foreign judgment in the Superior Court of Fulton County, Georgia, Civil Action File No. 2017CV288416.  NCSE is now pursuing post-judgment discovery.

Carlton Fields Jorden Burt, P.A.

This action was filed on May 18, 2017 by a law firm that represented the Company prior to the spin-out of the educational software business in 2016 with the intent of collection past due invoices in the aggregate amount of $241,828.  The Company believes it has strong defenses against any such action and anticipates a settlement upon completion of certain funding activities. The Company has recorded a liability in the amount of $241,828 on its balance sheet at December 31, 2018. The Company has negotiated a settlement to this claim subject to funding.

Randstad General Partner (US) LLC D/B/A Tatum

A former service provider of the Company has filed an action in Georgia to collect the amount of $44,365 for services provided to the Company. On October 18, 2018, the Superior Court of Fulton County, State of George issued an Order & Final Judgment against the Company in the amount of $44,365 plus an additional $11,001 of accrued interest. The Company has accrued the amount of $55,366 on its balance sheet at March 31. 2019 in connection with this claim. This claim was settled for a one-time payment of $5,000 made by a shareholder for the benefit of the Company on July 2, 2019. 

27

ITEM 1A. RISK FACTORS.

We believe there are no changes that constitute material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2018.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3.  DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4.  MINE SAFETY DISCLOSURES.

Not applicable to the Company’s operations.

ITEM 5.  OTHER INFORMATION.

None.

ITEM 6.  EXHIBITS.

Exhibit Number	Description
31.1*	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS **	XBRL INSTANCE DOCUMENT
101.SCH **	XBRL TAXONOMY EXTENSION SCHEMA
101.CAL **	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
101.DEF **	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
101.LAB **	XBRL TAXONOMY EXTENSION LABEL LINKBASE
101.PRE **	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

* Filed herewith.

** Furnished herewith.

28

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TRUE NATURE HOLDING, INC.
Dated: August 14, 2019	By:	/s/ James Crone
		James Crone
		Interim Chief Executive Officer, President, and Interim Chief Financial Officer

29

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, James Crone, certify that:

1. I have reviewed this quarterly report on Form 10-Q of True Nature Holding, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2019

/s/ James Crone

James Crone

Interim Chief Executive Officer, President, and Interim Chief Financial Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

I, James Crone, certify that:

1. I have reviewed this quarterly report on Form 10-Q of True Nature Holding, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 14, 2019 

/s/ James Crone

James Crone

Interim Chief Executive Officer, President, and Interim Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of True Nature Holding, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2019, as filed with the Securities and Exchange Commission on the date hereof, I, James Crone, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1. The quarterly report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ James Crone

Interim Chief Executive Officer, President, and Interim Chief Financial Officer

Dated: August 14, 2019 

XML

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Aug. 08, 2019
Document Information Line Items
Entity Registrant Name	True Nature Holding, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		41,625,627
Amendment Flag	false
Entity Central Index Key	0000802257
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Ex Transition Period	true
Entity Interactive Data Current	Yes

XML

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 284	$ 1,304
Prepaid expenses	0	2,500
Total current assets	284	3,804
Total Assets	284	3,804
Current liabilities
Accounts payable	811,300	794,466
Accrued liabilities	184,044	117,085
Due to related parties	50,099	13,948
Accrued interest	78,504	60,381
Notes payable	0	30,000
Convertible notes payable, net of discount of $117,198 and $86,520	406,995	247,590
Convertible note payable, in default	122,166	196,270
Note payable, related party - current portion	198,000	75,000
Total current liabilities	1,851,108	1,534,740
Notes payable, related party - non current portion	0	123,000
Total Liabilities	1,851,108	1,657,740
Commitments and contingencies
Stockholders' equity (deficit)
Preferred stock, $0.01 par value, 100,000,000 shares authorized, no shares issued or outstanding as of June 30, 2019 and December 31, 2018	0	0
Common stock, $0.01 par value, 500,000,000 shares authorized, 39,077,259 and 31,598,236 shares issued and outstanding as of June 30, 2019 and December 31, 2018	390,774	315,982
Additional paid-in capital	6,370,513	5,684,208
Stock payable	37,186	37,186
Accumulated deficit	(8,649,297)	(7,691,312)
Total (deficiency in) stockholders' equity	(1,850,824)	(1,653,936)
Total liabilities and stockholders' equity	$ 284	$ 3,804

XML

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Convertible notes payable, discount (in Dollars)	$ 117,198	$ 86,520
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	100,000,000	100,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	39,077,259	31,598,236
Common stock, shares outstanding	39,077,259	31,598,236

XML

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenue	$ 0	$ 0	$ 0	$ 0
General and administrative	226,250	276,026	447,501	329,305
Total operating expenses	226,250	276,026	447,501	329,305
Net Operating Loss	(226,250)	(276,026)	(447,501)	(329,305)
Other income (expense):
Interest expense	(164,504)	(9,505)	(324,901)	(16,666)
Loss on conversion of accounts payable		(36,100)	(158,659)	(36,100)
Loss on legal settlement	(26,924)	0	(26,924)	0
Loss on conversion of notes	(58,935)		(158,659)	(36,100)
Total other expense	(250,363)	(45,605)	(510,484)	(52,766)
Loss before provision for income taxes	(476,613)	(321,631)	(957,985)	(382,071)
Provision for income taxes	0	0	0	0
Net loss	$ (476,613)	$ (321,631)	$ (957,985)	$ (382,071)
Net loss per share - basic (in Dollars per share)	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.02)
Net loss per share - diluted (in Dollars per share)	$ (0.01)	$ (0.01)	$ (0.03)	$ (0.02)
Weighted average shares outstanding - basic (in Shares)	33,986,267	21,702,295	33,188,078	21,397,055
Weighted average shares outstanding - diluted (in Shares)	33,983,267	21,702,295	33,188,078	21,397,055

XML

Consolidated Statements of Changes in Stockholders' Deficit - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member] Discount on Notes Payable Due to Conversion Feature [Member]	Additional Paid-in Capital [Member] Discount on Note Payable Due to Warrants [Member]	Additional Paid-in Capital [Member]	Stock Payable [Member]	Retained Earnings [Member]	Discount on Notes Payable Due to Conversion Feature [Member]	Discount on Note Payable Due to Warrants [Member]	Total
Balance, at Dec. 31, 2017	$ 189,309			$ 4,659,713	$ 39,886	$ (6,276,159)			$ (1,387,251)
Balance, (in Shares) at Dec. 31, 2017	18,930,874
Stock issued for services	$ 31,056			217,709					248,765
Stock issued for services (in Shares)	3,105,628
Stock to be issued for services					22,900				22,900
Stock issued as compensation	$ 16,474			137,399					$ 153,873
Stock issued as compensation (in Shares)	1,647,431								800,000
Stock issue for conversion	$ 5,271			49,544					$ 54,815
Stock issue for conversion (in Shares)	527,064
Discount on notes payable									0
Imputed interest				4,500					4,500
Net loss						(382,071)			(382,071)
Balance, at Jun. 30, 2018	$ 242,110			5,068,865	62,786	(6,658,230)			(1,284,469)
Balance, (in Shares) at Jun. 30, 2018	24,210,997
Balance, at Mar. 31, 2018	$ 208,360			4,841,045	39,886	(6,336,599)			(1,247,308)
Balance, (in Shares) at Mar. 31, 2018	20,835,997
Stock issued for services	$ 30,750			214,830					245,580
Stock issued for services (in Shares)	3,075,000
Stock to be issued for services					22,900				22,900
Stock issued as compensation	$ 3,000			10,740					13,740
Stock issued as compensation (in Shares)	300,000
Imputed interest				2,250					2,250
Net loss						(321,631)			(321,631)
Balance, at Jun. 30, 2018	$ 242,110			5,068,865	62,786	(6,658,230)			(1,284,469)
Balance, (in Shares) at Jun. 30, 2018	24,210,997
Balance, at Dec. 31, 2018	$ 315,982			5,684,208	37,186	(7,691,312)			$ (1,653,936)
Balance, (in Shares) at Dec. 31, 2018	31,598,236								31,598,236
Stock issued for services	$ 2,000			15,480					$ 17,480
Stock issued for services (in Shares)	200,000
Stock to be issued for services									$ 7,500
Stock issued as compensation	$ 10,000			(10,000)
Stock issued as compensation (in Shares)	1,000,000								1,000,000
Stock issue for conversion	$ 52,780			302,629					$ 355,409
Stock issue for conversion (in Shares)	5,278,069
Shares issued for legal settlement	$ 14,012			87,016					101,028
Shares issued for legal settlement (in Shares)	1,401,224
Discount on notes payable		$ 223,087	$ 34,500				$ 223,087	$ 34,500	223,087
Cancellation of shares	$ (4,000)			4,000
Cancellation of shares (in Shares)	(400,000)
Vesting of shares issued to employees				25,093					25,093
Imputed interest				4,500					4,500
Net loss						(957,985)			(957,985)
Balance, at Jun. 30, 2019	$ 390,774			6,370,513	37,186	(8,649,297)			$ (1,850,824)
Balance, (in Shares) at Jun. 30, 2019	39,077,529								39,077,259
Balance, at Mar. 31, 2019	$ 333,168			5,993,643	37,186	(8,172,684)			$ (1,808,687)
Balance, (in Shares) at Mar. 31, 2019	33,316,861
Stock issued as compensation	$ 10,000			(10,000)
Stock issued as compensation (in Shares)	1,000,000
Stock issue for conversion	$ 33,594			131,831					165,425
Stock issue for conversion (in Shares)	3,359,444
Shares issued for legal settlement	$ 14,012			87,016					101,028
Shares issued for legal settlement (in Shares)	1,401,224
Discount on notes payable		$ 143,555					$ 143,555
Vesting of shares issued to employees				22,218					22,218
Imputed interest				2,250					2,250
Net loss						(476,613)			(476,613)
Balance, at Jun. 30, 2019	$ 390,774			$ 6,370,513	$ 37,186	$ (8,649,297)			$ (1,850,824)
Balance, (in Shares) at Jun. 30, 2019	39,077,529								39,077,259

XML

Condensed Consolidated Statement of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (957,985)	$ (382,071)
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on conversion of notes payable to common stock	158,659	36,100
Loss on legal settlement	26,924	0
Loss on conversion of accrued expenses	158,659	36,100
Imputed interest	4,500	4,500
Amortization of discount on notes payable	261,035	0
Stock based compensation	42,573	47,620
Changes in assets and liabilities:
Prepaid expenses	2,500	0
Accounts payable	16,834	214,597
Accrued liabilities	66,959	50,000
Deferred revenue	0	1,000
Due to related parties	36,151	(24,563)
Accrued interest	37,508	9,822
Net cash provided by (used in) operating activities	(304,342)	(42,995)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable, net of payments to vendors	313,558	0
Principal payments on notes payable	(10,236)	0
Advances from related parties	0	44,103
Net cash provided by financing activities	303,322	44,103
Net increase (decrease) in cash and cash equivalents	(1,020)	1,108
Cash and cash equivalents at beginning of period	1,304	0
Cash and cash equivalents at end of period	284	1,108
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	2,236	0
Income taxes paid	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued for satisfaction of payables	0	396,633
Par value of shares returned for cancellation	4,000	0
Stock issued for debt conversion	196,750	0
Stock issued for legal settlement	74,104	0
Discount due to warrants	34,500	0
Beneficial conversion feature	$ 223,087	$ 0

XML

Note 1 - Description of Business

6 Months Ended

Jun. 30, 2019

Disclosure Text Block [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

Note 1 – Description of Business

Company Overview

True Nature Holding, Inc. (the “Company,” “we,” “us,” or “our”), previously known as Trunity Holdings, Inc., a Delaware corporation, became a publicly-traded company through a reverse triangular merger with Brain Tree International, Inc., a Utah corporation (“BTI”). Trunity Holdings, Inc. was the parent company of our educational business, named Trunity, Inc., which was formed on July 28, 2009 through the acquisition of certain intellectual property from its three founders. On December 9, 2015 the Company made a decision to restructure Trunity Holdings, Inc., having acquired Newco4pharmacy, LLC, a development stage business aimed at a roll-up of compounding pharmacy businesses. As a part of such restructuring, we competed a “spin out” transaction of our educational business line to our shareholders as of December 31, 2015.

Our business during 2018, which has continued into 2019 is focused in the area of software and solutions, predominantly in the healthcare sector, generally described as the healthcare information and technology (HCIT) market. We announced plans for a personal healthcare records (PHR) application, SimpleHIPAA, which will allow individuals to track their personal healthcare information. This type of application is intended to include information from the individual, as well as data from healthcare providers extracted from their electronic healthcare records (EHR) systems. Data from individuals might include manual input or from personal devices such as watches, activity trackers and diagnostic devices such as glucose meters or blood pressure measuring devices. Information from healthcare providers might include data gathered from regular doctor visits, specialized care, or even a simple as prescription information from a pharmacy.

While this project continues, we are also evaluating other applications, generally, but not exclusively in the healthcare area. We believe that new technologies such as voice recognition, virtual reality and robotics will all provide excellent vehicles to update traditional information management systems and will find quick acceptance in the healthcare field as well as other large and more traditional markets. We believe the need for compliance in other industries, similar to the need in healthcare for HIPAA and data security represents opportunity for growth over and above our healthcare efforts.

Within the healthcare arena one of the most active areas involves software that provides “interoperability”, the interfacing of systems and data so that information may be shared effectively. We believe there will be many opportunities in this application area, as older systems are integrated with newer, or more specialized systems, but we have not taken any actions in pursuit of these opportunities and no guarantee can be made if we enter this space, that we will be successful. These same needs exist in other market areas and we may consider applications for these markets as well as our healthcare efforts.

XML

Note 2 - Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

Note 2 – Summary of Significant Accounting Policies

Basis of Accounting – The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to interim financial reporting as prescribed by the Securities and Exchange Commission (the “SEC”). The results for the interim periods are not necessarily indicative of results for the entire year. These interim financial statements do not include all disclosures required by U.S. generally accepted accounting principles (“GAAP”), and should be read in conjunction with the consolidated financial statements and notes thereto filed with the SEC in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018. In the opinion of management, the unaudited Condensed Consolidated Financial Statements contained in this report include all known accruals and adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods reported herein. Any such adjustments are of a normal recurring nature.

Use of Estimates - The preparation of these financial statements requires our management to make estimates and assumptions about future events that affect the amounts reported in the financial statements and related notes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment.

Comprehensive Loss – Comprehensive income (loss) as defined includes all changes in equity during a period from non-owner sources. Items included in the Company’s comprehensive loss consist of unrealized gains (losses) on securities.

Cash -All highly liquid investments with a maturity date of three months or less at the date of purchase are cash equivalents.   

Revenue Recognition – On January 1, 2018, we adopted Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (ASC) Topic 605, Revenue Recognition (Topic 605). Results for reporting periods beginning after January 1, 2018 are presented under Topic 606. The impact of adopting the new revenue standard was not material to our financial statements and there was no adjustment to beginning retained earnings on January 1, 2018.

Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

We determine revenue recognition through the following steps:

● identification of the contract, or contracts, with a customer;

● identification of the performance obligations in the contract;

● determination of the transaction price;

● allocation of the transaction price to the performance obligations in the contract; and

● recognition of revenue when, or as, we satisfy a performance obligation.

Stock-Based Compensation-We recognize the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation cost for stock options are estimated at the grant date based on each option’s fair-value as calculated by the Black-Scholes-Merton (“BSM”) option-pricing model. Share-based compensation arrangements may include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.

Equity instruments issued to those other than employees are recorded on the basis of the fair value of the instruments. In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant.

Convertible Instruments-The Company reviews the terms of convertible debt and equity instruments to determine whether there are conversion features or embedded derivative instruments including embedded conversion options that are required to be bifurcated and accounted for separately as a derivative financial instrument. In circumstances where the convertible instrument contains more than one embedded derivative instrument, including conversion options that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single compound instrument. Also, in connection with the sale of convertible debt and equity instruments, the Company may issue free standing warrants that may, depending on their terms, be accounted for as derivative instrument liabilities, rather than as equity. When convertible debt or equity instruments contain embedded derivative instruments that are to be bifurcated and accounted for separately, the total proceeds allocated to the convertible host instruments are first allocated to the fair value of the bifurcated derivative instrument. The remaining proceeds, if any, are then allocated to the convertible instruments themselves, usually resulting in those instruments being recorded at a discount from their face amount. When the Company issues debt securities, which bear interest at rates that are lower than market rates, the Company recognizes a discount, which is offset against the carrying value of the debt. Such discount from the face value of the debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to income. In addition, certain conversion features are recognized as beneficial conversion features to the extent the conversion price as defined in the convertible note is less than the closing stock price on the issuance of the convertible notes.

Common Stock Purchase Warrants-The Company accounts for common stock purchase warrants in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 815, Accounting for Derivative Instruments and Hedging Activities. As is consistent with its handling of stock compensation and embedded derivative instruments, the Company’s cost for stock warrants is estimated at the grant date based on each warrant’s fair-value as calculated by the BSM option-pricing model value method for valuing the impact of the expense associated with these warrants.

Stockholders’ Equity-Shares of common stock issued for other than cash have been assigned amounts equivalent to the fair value of the service or assets received in exchange. Common stock share and per share amounts in these financial statements have been adjusted for the effects of a one for 101 reverse stock split that occurred in January 2016. 

Per Share Data-Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the year. Diluted loss per share is computed by dividing net loss by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to warrants, options and convertible instruments.

The Company has excluded all common equivalent shares outstanding for warrants, options and convertible instruments to purchase common stock from the calculation of diluted net loss per share because all such securities are anti-dilutive for the periods presented. As of June 30, 2019, the Company had outstanding 1,425,000 warrants and 67,879 options excluded from the calculation of diluted net loss; as of December 31, 2018, the Company had outstanding 1,167,653 warrants and 67,879 options excluded from the calculation of diluted net loss.

Income Taxes- The Company accounts for income taxes under the asset and liability method which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s condensed consolidated financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than possible enactments of changes in the tax laws or rates.

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses, the sale of profitable divisions and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance.  The following table reflects the deferred tax asset balance at June 30, 2019:

	June 30, 2019
Deferred tax Asset		718,332
Less: valuation allowance		(718,332	)
Net deferred tax asset		-

The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the condensed consolidated financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is generally no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012.

Business Combinations- The Company accounts for business combinations by recognizing the assets acquired, liabilities assumed, contractual contingencies, and contingent consideration at their fair values on the acquisition date. The purchase price allocation process requires management to make significant estimates and assumptions, especially with respect to intangible assets, estimated contingent consideration payments and pre-acquisition contingencies. Examples of critical estimates in valuing certain of the intangible assets we have acquired or may acquire in the future include but are not limited to:

● future expected cash flows from product sales, support agreements, consulting contracts, other customer contracts, and acquired developed technologies and patents; and

● discount rates utilized in valuation estimates.

Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results. Additionally, any change in the fair value of the acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, such as changes in our estimates of relevant revenue or other targets, will be recognized in earnings in the period of the estimated fair value change. A change in fair value of the acquisition-related contingent consideration or the occurrence of events that cause results to differ from our estimates or assumptions could have a material effect on the condensed consolidated financial position, statements of operations or cash flows in the period of the change in the estimate.

Impairment of Long-Lived Assets-Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed would be separately presented in the condensed consolidated balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and are no longer depreciated. The assets and liabilities of a disposal group classified as held-for-sale would be presented separately in the appropriate asset and liability sections of the condensed consolidated balance sheet, if material. No impairment losses have been realized for the periods presented.

Financial Instruments and Fair Values-The fair value of a financial instrument represents the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. Fair value estimates are made at a specific point in time, based upon relevant market information about the financial instrument. In determining fair value, we use various valuation methodologies and prioritize the use of observable inputs. We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:

Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable.

Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates.

Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability.

The use of observable and unobservable inputs and their significant in measuring fair value are reflected in our hierarchy assessment. The carrying amount of cash, prepaid assets, accounts payable and accrued liabilities approximates fair value due to the short-term maturities of these instruments. Because cash and cash equivalents are readily liquidated, management classifies these values as Level 1. The fair value of the debentures, approximate their book value as the instruments are short-term in nature and contain market rates of interest. Because there is no ready market or observable transactions, management classifies the debentures as Level 3.

Recently Issued Accounting Standards-There are various other updates recently issued, most of which represent technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s condensed consolidated financial position, results of operations or cash flows.

XML

Note 3 - Financial Condition and Going Concern

6 Months Ended

Jun. 30, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Substantial Doubt about Going Concern [Text Block]

Note 3 – Financial Condition and Going Concern

As of June 30, 2019, the Company had cash of $284, current liabilities of $1,851,108, and has incurred a loss from operations. True Nature Holding’s principal operation is the development and deployment of software and systems for the healthcare marketplace. The Company develops solutions in a) healthcare records, b) the sale of applications in the health and wellness area from 3^rd parties in addition to its own developed products. The Company’s activities are subject to significant risks and uncertainties, including failing to secure additional funding to execute its business plan.

As a result of these factors, there is substantial doubt about the ability of the Company to continue as a going concern. The Company’s continuance is dependent on raising capital and generating revenues sufficient to sustain operations. The Company believes that the necessary capital will be raised and has entered into discussions to do so with certain individuals and companies. However, as of the date of these condensed consolidated financial statements, no formal agreement exists.

The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions. 

XML

Note 4 - Related Party Transactions

6 Months Ended

Jun. 30, 2019

Related Party Transactions [Abstract]

Related Party Transactions Disclosure [Text Block]

Note 4 – Related Party Transactions

Six months ended June 30, 2019:

On March 11, 2019, the Company issued 100,000 shares of common stock to its President as compensation, and charged the fair value in the amount of $8,740 to operations.

On March 11, 2019, the Company issued 100,000 shares of common stock to a board member as compensation, and charged the fair value in the amount of $8,740 to operations.

During the six months ended June 30, 2019, the Company accrued the amount of $2,875 in connection with the vested portion of a common stock award granted to its President.

At June 30, 2019, the Company has the following amounts due to related parties:

● Due to shareholders for accounts payable paid on behalf of the Company and accrued interest: $50,099

● Note payable in the amount of $75,000 related to reclassification of accounts payable (see note 5, “July 2017 Note”)

● Note payable in the amount of $65,000 related to consulting services provided (see note 5, “Consulting Services Note”)

● Note payable in the amount of $58,000 related to accounts payable paid on behalf of the Company (see note 5, “Trade Payables Note”)

Six months ended June 30, 2018:

On January 29, 2018, the Company converted outstanding accounts payable due to an investor in the amount of $54,815 for 527,064 restricted shares of the Company’s common stock. The cost to the Company for this issuance is $54,815, based on the closing price on the date of issuance. As the conversion amount equals the share value, no gain or loss was recorded.

On January 29, 2018, the Company converted accrued officer compensation in the amount of $93,333 into 897,432 restricted shares of the Company’s common stock. The cost to the Company for this issuance is $93,333, based on the closing price on the date of issuance. As the conversion amount equals the share value, no gain or loss was recorded.

On April 23, 2018, the Company issued 600,000 shares of common stock with a value of $48,000 to an investor, and an additional 600,000 shares of common stock with a value of $48,000 to a not for profit entity at the request of the investor due to conversion of $96,000 of accounts payable, no gain or loss was recognized due to stock price matching the amount converted.

On April 23, 2018, the Company issued 500,000 shares of common stock to its President, subject to certain vesting conditions: (i) 100,000 shares vest when the President has been employed 90 days from the effective date of the employment agreement; (ii) 100,000 shares vest when the President has been employed one year from the effective date of the employment agreement; (iii) 100,000 shares vest when the President has been employed two years from the effective date of the employment agreement; (iv) 100,000 shares vest when the Company completes a capital raise of $2,000,000; (v) 100,000 shares vest when the Company reports $20,000,000 in gross revenue. The Company valued the shares at the fair market value of $0.10 per share, or a total value of $50,000. During the three months ended June 30, 2018, the total amount of $13,740 was charged to operations pursuant to the various vesting conditions.

On June 13, 2018, the Company issued 100,000 shares of common stock with a fair value of $8,380 to its President as a bonus.

On June 14, 2018, the Company issued 100,000 shares of common stock with a fair value of $9,000 to its chairman as a bonus. Also on June 14, 2018, the Company issued 100,000 shares of common stock with a fair value of $9,000 to a board member as a bonus.

On June 14, 2018, the Company issued to an investor 1,100,000 restricted shares of the Company’s common stock with a fair value of $95,700 for reimbursement of $60,000 of accrued expenses paid on behalf of the Company and for services provided. The Company recognized a loss on conversion of $35,700 due to share price exceeding the value of the stock granted.

The Company accrued officer’s compensation during the six months ended June 30, 2018 in the amount of $50,000 and imputed interest expense of $4,500 on a note payable to a related party in the amount of $75,000 (see note 5).

XML

Note 5 - Debt

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

Note 5 – Debt

March 2016 Convertible Note A

On March 18, 2016, the Company issued a 12% Convertible Promissory Note (the “Convertible Note A”) in the principal amount of $60,000 to a lender. Upon issuance of the Convertible Note A, the lender was awarded 15,000 restricted common stock as an origination fee which includes piggy back registration rights. On September 19, 2016, the Company issued the lender an additional 15,000 restricted common stock at a price of $0.30 per share to extend the term of the loan agreement indefinitely. The cost to the Company was $4,050 in interest expense.  On August 10, 2017, the Company issued 25,000 shares of common stock with a fair value of $3,750 for accrued interest through August 1, 2017 in the amount of $7,860.  In April 2018, the Company issued 75,000 shares of common stock with a value of $7,500 as consideration for an extension of the term of the loan to July 1, 2018, and on August 13, 2018, the Company issued an additional 75,000 shares of common stock with a value of $6,750 for an extension of the term of the loan to October 31, 2018. During the six months ended June 30, 2019, the lender converted principal in the amount of $15,000 into 120,000 shares of common stock. The Company recorded a loss in the amount of $13,867 on this conversion. The Company accrued interest in the amount of $2,900 on this note during the six months ended June 30, 2019. At June 30, 2019, the principal amount of the March 2016 Convertible Note A was $45,000 and accrued interest was $4,379. 

Pursuant to the terms of the Convertible Note A, the Company is obligated to pay monthly installments of not less than $1,000 the first of each month commencing the month following the execution of the Convertible Note A until its maturity on September 16, 2016 at which time the Company is obligated to repay the full principal amount of the Convertible Note A. The Convertible Note A is convertible by the holder at any time into shares of the Company’s common stock at price of $1.00 per share, and throughout the duration of the note, the holder has the right to participate in any financing the Company may engage in upon the same terms and conditions as all other investors. The Company allocated the face value of the Convertible Note A to the shares and the note based on relative fair values, and the amount allocated to the shares of $18,750 was recorded as a discount against the note.

The beneficial conversion feature of $9,375 was recorded as a debt discount with an offsetting entry to additional paid-in capital decreasing the note payable and increasing debt discount. The debt discount is being amortized to interest expense over the term of the debt. For the year ended December 31, 2016, debt discount amortization related to the Convertible Note A was $28,125.  There was no amortization of the discount during the six months ended June 30, 2019.

August 2014 Convertible Debentures (Series C)

As part of the restructuring all debentures issued by Trunity Holdings, Inc., to fund the former, educational business were eligible to participate in a debt conversion; however, one debenture holder that was issued a Series C Convertible Debenture (the “Series C Debenture”) in August 2014 with an aggregate face value of $100,000 in exchange for the cancellation of Series B Convertible Debentures with a carrying value of $110,833 did not convert such debenture. The Series C Debenture accrues interest at an annual rate of 10%, matured November 2015, and is convertible into our common stock at a conversion rate of $20.20 per share. The holders of the Series C Debenture also received five-year warrants to acquire up to 4,950 shares post-split of common stock for an exercise price of $20.20 per share. The former educational business allocated the face value of the Series C Debenture to the warrants and the debentures based on its relative fair values, and allocated to the warrants, which was recorded as a discount against the Series C Debenture, with an offsetting entry to additional paid-in capital. The discount was fully expensed upon execution of the new debentures as debt extinguishment costs within discontinued operations. The Company accrued interest in the amount of $5,534 on this note during the six months ended June 30, 2019. As of June 30, 2019, and December 31, 2018, the carrying value of this Series C Debenture was $110,833 and accrued interest expense of $52,121 and $46,587, respectively. The Series C Debenture is currently in default.

November 2014 Convertible Debentures (Series D)

As part of the restructuring all debentures issued by Trunity Holdings, Inc., to fund the former, educational business were eligible to participate in a debt conversion; however, one debenture holder that was issued a Series D Convertible Debenture (the “Series D Debenture”) in November 2014 with an aggregate face value of $10,000 in exchange for the cancellation of Series B Convertible Debenture with a carrying value of $11,333 did not participate in the debt conversion restructuring. The Series D Debenture accrues interest at an annual rate of 12%, matured November 2015, and is convertible into our common stock at a conversion rate of $16.67 per share. The holders of the Series D Debenture also received five-year warrants to acquire up to 495 shares of common stock for an exercise price of $20.20 per share on a post-split basis. The former educational business allocated the face value of the Series D Debenture to the warrants and the debentures based on their relative fair values, and allocated to the warrants, which was recorded as a discount against the Series D Debenture, with an offsetting entry to additional paid-in capital. The discount was fully expensed upon execution of the new debentures as debt extinguishment costs within discontinued operations. The Company accrued interest in the amount of $679 on this note during the six months ended June 30, 2019. As of June 30, 2019, and December 31, 2018, the carrying value of the Series D Debenture was $11,333 and accrued interest was $6,340 and $5,661, respectively.   The Series D Debenture is currently in default.

Short Term Loan

As a result of the acquisition of P3 Compounding of Georgia, LLC (“P3”) the Company had a short-term convertible note with a loan agency in the principal amount of $52,000 for the purchase of future sales and credit card receivables of P3. Under the terms of the receivable purchase agreement, the Company purchased an advance of $50,000 plus $2,000 for origination costs with a 10.5% daily interest rate to be repaid over 160 days at a repayment amount of $451.75 per day. The origination fee and interest were recorded as debt discount on the date of issuance in the amount of $22,280 and $22,280 was amortized during the year ending December 31, 2016. During the six months ended June 30, 2019, principal in the amount of $74,104 was converted into 1,401,224 shares of common stock; a loss in the amount of $16,955 was recorded on this transaction. The principal balance due under this note was $0 at June 30, 2019.

July 2017 Note

On July 10, 2017, the Company negotiated the reclassification of $75,000 in accounts payable to a loan payable (the “July 2017 Note”).  The July 2017 Note is due no later than 90 days after the receipt of a minimum of $1,000,000 of funding. The July 2017 Note bears no interest; however, if it is not paid by the due date, interest will accrue at the rate of 12% per year. During the six months ended June 30, 2019, the Company imputed interest in the amount of $4,500 on the July 2017 Note.

July 2018 RU Promissory Note

On July 26, 2018, the Company entered into an agreement with Resources Unlimited NW LLC (“RU”) pursuant to which RU provides business development services to the Company for a period of six months. As compensation for these services, the Company issued RU 250,000 shares of common stock with a fair value of $20,000 and a six month note payable in the amount of $30,000 (the “RU Note”). The RU Note bears interest at the rate of 12% per year; principal and interest are due on January 26, 2019. During the six months ended June 30, 2019, the Company accrued interest in the amount of $1,776 on the July 2018 RU Promissory Note. During the six months ended June 30, 2019, the Company converted principal and accrued in the amounts of $30,000 and $3,344, respectively, into an aggregate of 400,000 shares of common stock; a loss in the amount of $2,637 was recorded on this transaction. The principal balance due under this note was $0 at June 30, 2019.

Power Up Note 1

On July 5, 2018, the Company entered into a Securities Purchase Agreement with Power Up Lending Group Ltd. (“Power Up”) pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 1”) in the aggregate principal amount of $38,000. The Power Up Note entitles the holder to 12% interest per annum and matures on April 15, 2019.  Under the Power Up Note 1, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 1 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 1, at a price equal to 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, but no lower than $0.00006 (fixed price floor), provided, however, that Power Up may not convert the Power Up Note 1 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. On January 1, 2019, the Power Up Note 1 became convertible, and the Company recorded a discount in connection with the beneficial conversion feature in the amount of $9,032; $9,032 of this amount was charged to interest expense during the six months ended June 30, 2019. If the Company prepays the Power Up Note 1 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 1, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 1, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 1; $2,077 of this amount was charged to interest during the year ended six months ended June 30, 2019. During the year ended December 31, 2018, the Company paid principal and accrued interest in the amount of $27,764 and $2,236, respectively, on the Power Up Note 1. The Company accrued interest in the amount of $58 on this note during the six months ended June 30, 2019. During the six months ended June 30, 2019, the Company paid the remaining principal and accrued interest in the amount of $10,236 and $58, respectively, along with a prepayment penalty in the amount of $16,072 on the Power Up Note 1; The principal balance due under this note was $0 at June 30, 2019.

Power Up Note 2 

On August 10, 2018, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 2”) in the aggregate principal amount of $33,000. The Power Up Note 2 entitles the holder to 12% interest per annum and matures on May 14, 2019. Under the Power Up Note 2, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 2 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 2, at a price equal to 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, but no lower than $0.00006 (fixed price floor), provided, however, that Power Up may not convert the Power Up Note 2 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. On February 5, 2019, the Power Up Note 2 became convertible; there was no discount associated with the conversion feature of Power Up Note 2. If the Company prepays the Power Up Note 2 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 2, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 2; $3,000 was amortized to interest expense during the six months ended June 30, 2019. During the six months ended June 30, 2019 the Company also recorded a discount to the Power Up Note 2 in the amount of $32,500 related to a beneficial conversion feature; this amount was charged to operations during the six months ended June 30, 2019.  During the six months ended June 30 2019, principal and accrued interest in the amount of $33,000 and $1,980, respectively, were converted into a total of 624,993 shares of the Company’s common stock. The Company recognized a loss in the amount of $34,101 on these conversions which was charged to operations during the six months ended June 30, 2019. The Company accrued interest in the amount of $418 on the Power Up Note 2 during the six months ended June 30, 2019. The principal balance due under this note was $0 at June 30, 2019.

Power Up Note 3

On September 18, 2018, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 3”) in the aggregate principal amount of $38,000. The Power Up Note 3 entitles the holder to 12% interest per annum and matures on June 30, 2019.  Under the Power Up Note 3, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 3 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 3, at a price equal to 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, but no lower than $0.00006 (fixed price floor), provided, however, that Power Up may not convert the Power Up Note 3 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. On March 17, 2019, the Power Up Note 3 became convertible, and the Company recorded a discount in connection with the beneficial conversion feature in the amount of $38,000; $38,000 of this amount was charged to interest expense during the six months ended June 30, 2019. If the Company prepays the Power Up Note 3 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 3, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 3, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 3; $3,000 was amortized to interest expense during the six months ended June 30, 2019. During the six months ended June 30, 2019, principal and accrued interest in the amount of $38,000 and $2,280, respectively, were converted into a total of 1,173,632 shares of the Company’s common stock. The Company recognized a loss in the amount of $45,724 on these conversions which was charged to operations during the six months ended June 30, 2019. The Company accrued interest in the amount of $1,592 on Power Up Note 3 during the six months ended June 30, 2019. The principal balance under this note was $0 at June 30, 2019.

Power Up Note 4

On November 9, 2018, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 4”) in the aggregate principal amount of $33,000. The Power Up Note 4 entitles the holder to 12% interest per annum and matures on August 31, 2019.  Under the Power Up Note 4, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 4 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 4, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 4 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. On May 8, 2019, the Power Up Note 4 became convertible, and the Company recorded a discount in connection with the beneficial conversion feature in the amount of $33,000; $33,000 of this amount was charged to interest expense during the six months ended June 30, 2019. If the Company prepays the Power Up Note 4 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 4, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 4, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 4; $3,000 was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest in the amount of $976 on Power Up Note 4 during the six months ended June 30, 2019. During the six months ended June 30, 2019, principal and accrued interest in the amount of $33,000 and $1,980, respectively, were converted into a total of 1,619,444 shares of the Company’s common stock. The Company recognized a loss in the amount of $63,443 on these conversions which was charged to operations during the six months ended June 30, 2019. The principal balance under this note was $0 at June 30, 2019.

 Auctus Note

On November 26, 2018, the Company entered into a Securities Purchase Agreement with Auctus Fund, LLC (“Auctus”) pursuant to which Auctus agreed to purchase a convertible promissory note (the “Auctus Note”) in the principal amount of $125,000. The Auctus Note entitles the holder to 12% interest per annum and matures on August 26, 2019.  Under the Auctus Note, Auctus may convert all or a portion of the outstanding principal of the Auctus Note into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Auctus Note, at a price equal to the higher of the variable conversion price or $0.00003 per share.  The variable conversion price shall mean 55% of the lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Auctus may not convert the Auctus Note to the extent that such conversion would result in beneficial ownership by Auctus and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Auctus Note within 90 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 135%; if such prepayment is made between the 91st day and the 180th day after the issuance of the Auctus Note, then such redemption premium is 150%. After the 180th day following the issuance of the Auctus Note, there shall be no further right of prepayment. In connection with the Auctus Note, the Company issued five year warrants to purchase 625,000 shares of the Company’s common stock at a price of $0.10 per share. The Company valued these warrants at $39,595, and recorded this amount as a discount to the Auctus Note; $26,251 of this amount was amortized to interest expense during the six months ended June 30, 2019. On May 25, 2019, the Auctus Note became convertible, and the Company recorded a discount in connection with the beneficial conversion feature in the amount of $125,000; $31,079 of this amount was charged to interest expense during the six months ended June 30, 2019. The Company also recorded an original issue discount in the amount of $13,500 in connection with the Auctus Note; $8,951 was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest in the amount of $7,393 on the Auctus Note during the six months ended June 30, 2019. During the six months ended June 30, 2019, principal and accrued interest in the amount of $23,209 and $8,301, respectively, were converted into a total of 1,000,000 shares of the Company’s common stock. The Company recognized a loss in the amount of $1,291 on these conversions which was charged to operations during the six months ended June 30, 2019. The principal balance under this note was $101,791 at June 30, 2019.

Crown Bridge Note 1

On December 19, 2018, the Company entered into a Securities Purchase Agreement with Crown Bridge Partners, LLC (“Crown Bridge”) pursuant to which Crown Bridge agreed to purchase a convertible promissory note (the “Crown Bridge Note 1”) in the principal amount of $40,000. The Crown Bridge Note 1 entitles the holder to 12% interest per annum and matures on September 19, 2019.  Under the Crown Bridge Note 1, Crown Bridge may convert all or a portion of the outstanding principal of the Crown Bridge Note 1 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Crown Bridge Note 1, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 55% of the lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Crown Bridge may not convert the Crown Bridge Note 1 to the extent that such conversion would result in beneficial ownership by Crown Bridge and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Crown Bridge Note 1 within 90 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 135%; if such prepayment is made between the 91st day and the 180th day after the issuance of the Crown Bridge Note 1, then such redemption premium is 150%. After the 180th day following the issuance of the Crown Bridge Note 1, there shall be no further right of prepayment. In connection with the Crown Bridge Note 1, the Company issued five year warrants to purchase 400,000 shares of the Company’s common stock at a price of $0.10 per share. The Company valued these warrants at $34,500, and recorded this amount as a discount to the Crown Bridge Note 1; $22,790 of this amount was amortized to interest expense during the three months ended June 30, 2019. On June 17, 2019, the Crown Bridge Note 1 became convertible, and the Company recorded a discount in connection with the beneficial conversion feature in the amount of $40,000; $17,961 of this amount was charged to interest expense during the six months ended June 30, 2019. The Company also recorded an original issue discount in the amount of $5,500 in connection with the Crown Bridge Note 1; $3,634 was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest in the amount of $2,381 on the Crown Bridge Note 1 during the six months ended June 30, 2019. During the six months ended June 30, 2019, principal in the amount of $9,598 was converted into a total of 340,000 shares of the Company’s common stock. The Company recognized a loss in the amount of $2,881 on this conversion which was charged to operations during the six months ended June 30, 2019. The principal balance under this note was $30,402 at June 30, 2019.

Consulting Services Note

On December 31, 2018, the Company entered into a note payable agreement with an investor for consulting services performed on behalf of the Company in the amount of $65,000 (the “Consulting Services Note”). The Consulting Services Note matures on March 21, 2020, and bears interest at the rate of 12% per annum. The Company recorded $3,868 in interest on the Consulting Services Note during the six months ended June 30, 2019. The principal balance under this note was $65,000 at June 30, 2019.

Trade Payables Note

On December 31, 2018, the Company entered into a note payable agreement with an investor for payments of trade accounts payable made by the investor on behalf of the Company in the amount of $58,000 (the “Trade Payables Note”). The Trade Payables Note matures on March 21, 2020, and bears interest at the rate of 12% per annum. The Company recorded $3,451 in interest on the Consulting Services Note during the six months ended June 30, 2019. The principal balance under this note was $58,000 at June 30, 2019.

Power Up Note 5

On January 2, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 5”) in the aggregate principal amount of $53,000. The Power Up Note 5 entitles the holder to 12% interest per annum and matures on October 31, 2019.  Under the Power Up Note 5, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 5 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 5, at a price equal to the higher of the variable conversion price or $0.00006 per share. The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 5 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 5 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 5, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 5, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 5; $2,238 was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest in the amount of $3,119 on the Power Up Note 5 during the six months ended June 30, 2019. The principal balance under this note was $53,000 at June 30, 2019.

Power Up Note 6

On February 11, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 6”) in the aggregate principal amount of $48,000. The Power Up Note 6 entitles the holder to 12% interest per annum and matures on November 30, 2019.  Under the Power Up Note 6, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 6 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 6, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 6 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 6 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 6, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 6, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 6; $1,598 was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest on the Power Up Note 6 in the amount of $1,598 during the six months ended June 30, 2019. The principal balance under this note was $48,000 at June 30, 2019.

Crown Bridge Note 2

On March 4, 2019, the Company entered into a Securities Purchase Agreement with Crown Bridge Partners, LLC (“Crown Bridge”) pursuant to which Crown Bridge agreed to purchase a convertible promissory note (the “Crown Bridge Note 2”) in the principal amount of $40,000. The Crown Bridge Note 2 entitles the holder to 12% interest per annum and matures on December 4, 2019.  Under the Crown Bridge Note 2, Crown Bridge may convert all or a portion of the outstanding principal of the Crown Bridge Note 2 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Crown Bridge Note 2, at a price equal to the higher of the variable conversion price or $0.00003 per share.  The variable conversion price  shall mean 55% of the lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Crown Bridge may not convert the Crown Bridge Note 2 to the extent that such conversion would result in beneficial ownership by Crown Bridge and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Crown Bridge Note 2 within 90 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 135%; if such prepayment is made between the 91st day and the 180th day after the issuance of the Crown Bridge Note 2, then such redemption premium is 150%. After the 180th day following the issuance of the Crown Bridge Note 2, there shall be no further right of prepayment. In connection with the Crown Bridge Note 2, the Company issued five year warrants to purchase 400,000 shares of the Company’s common stock at a price of $0.10 per share. The Company valued these warrants at $34,500, and recorded this amount as a discount to the Crown Bridge Note 2; $14,803 of this amount was amortized to interest expense during the six months ended June 30, 2019. The Company also recorded an original issue discount in the amount of $5,500 in connection with the Crown Bridge Note 2; $2,360 of this amount was amortized to interest expense during the six months ended June 30, 2019. The Company accrued interest expense in the amount of $2,761 on the Crown Bridge Note 2 during the six months ended June 30, 2019. The principal balance under this note was $40,000 at June 30, 2019.

Power Up Note 7

On March 18, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 7”) in the aggregate principal amount of $43,000. The Power Up Note 7 entitles the holder to 12% interest per annum and matures on January 30, 2020.  Under the Power Up Note 7, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 7 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 7, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 7 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 7 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 7, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 7, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 7; $981 was amortized to interest expense during the six months needed June 30, 2019. The Company accrued interest in the amount of $1,456 on the Power Up Note 7 during the six months ended June 30, 2019. The principal balance under this note was $43,000 at June 30, 2019.

Power Up Note 8

On April 1, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 8”) in the aggregate principal amount of $53,000. The Power Up Note 8 entitles the holder to 12% interest per annum and matures on January 30, 2020.  Under the Power Up Note 8, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 8 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 8, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 8 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 8 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 8, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 8, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 8; $883 was amortized to interest expense during the six months needed June 30, 2019. The Company accrued interest in the amount of $1,586 on the Power Up Note 8 during the six months ended June 30, 2019. The principal balance under this note was $53,000 at June 30, 2019.

Power Up Note 9

On May 2, 2019, the Company entered into a Securities Purchase Agreement with Power Up pursuant to which Power Up agreed to purchase a convertible promissory note (the “Power Up Note 9”) in the aggregate principal amount of $33,000. The Power Up Note 9 entitles the holder to 12% interest per annum and matures on February 28, 2020.  Under the Power Up Note 9, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 9 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 9, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 9 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock. If the Company prepays the Power Up Note 9 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 9, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 9, there shall be no further right of prepayment. The Company recorded an original issue discount in the amount of $3,000 in connection with the Power Up Note 9; $594 was amortized to interest expense during the six months needed June 30, 2019. The Company accrued interest in the amount of $662 on the Power Up Note 9 during the six months ended June 30, 2019. The principal balance under this note was $33,000 at June 30, 2019.

BHP Note

On June 4, 2019, the Company entered into a securities purchase agreement with BHP Capital NY, Inc., a New York corporation (“BHP”), pursuant to which BHP agreed to purchase a Convertible Promissory Note (the “BHP Note”) in the principal amount of $38,500.   The BHP Note the holder to 10% interest per annum and matures on March 4, 2020.  In the event the Company prepays the BHP Note beginning on the issuance date through the 180th day following the issuance date, the Company must pay BHP all of the outstanding principal and interest due plus a cash redemption premium ranging from 135% to 150%. After the 180th day following the issuance date, there is no further right of prepayment by the Company. BHP has no right of conversion under the BHP Note for a period of 180 days commencing on the issuance date. In the event the Company has not paid the BHP Note in full prior to 180 days from the issuance date, BHP may convert all or a portion of the outstanding principal of the BHP Note into shares of the Company’s common stock at a price per share at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price shall mean 55% of the lowest traded price of the Common Stock during the 25 trading day period ending on the last complete trading day prior to the date of conversion. BHP may not convert the BHP Note to the extent that such conversion would result in beneficial ownership by BHP and its affiliates of more than 4.99% of the issued and outstanding Common Stock. The BHP Note contains certain representations, warranties, covenants and events of default including if the Common Stock is suspended or delisted for trading on the OTC Marketplace or if the Company is delinquent in its periodic report filings with the SEC. In the event of default, as described in the BHP Note, at the option of BHP, it may consider the BHP Note immediately due and payable. The Company recorded an original issue discount in the amount of $3,000 in connection with the BHP Note; $522 was amortized to interest expense during the six months needed June 30, 2019. The Company accrued interest in the amount of $329 on the BHP Note during the six months ended June 30, 2019. The principal balance under this note was $38,500 at June 30, 2019.

Armada Note

On June 10, 2019, the Company entered into a securities purchase agreement with Armada Investment Fund, LLC (“Armada”) pursuant to which Armada agreed to purchase a convertible promissory note (the “Armada Note”) in the aggregate principal amount of $38,500. The Armada Note the holder to 10% interest per annum and matures on March 10, 2020.  In the event the Company prepays the Armada Note beginning on the issuance date through the 180th day following the Armada Issuance Date, the Company must pay Armada all of the outstanding principal and interest due plus a cash redemption premium ranging from 135% to 150%. After the 180th day following the Armada Issuance Date, there is no further right of prepayment by the Company. Armada has no right of conversion under the Armada Note for a period of 180 days commencing on the Armada Issuance Date. In the event the Company has not paid the Armada Note in full prior to 180 days from the Armada Issuance Date, Armada may convert all or a portion of the outstanding principal of the Armada Note into shares of the Company’s common stock at a price per share equal to the higher of the variable conversion price or $0.00006 per share. The variable conversion price shall mean 55% of the lowest traded price of the Common Stock during the 25 trading day period ending on the last complete trading day prior to the date of conversion. Armada may not convert the Armada Note to the extent that such conversion would result in beneficial ownership by Armada and its affiliates of more than 4.99% of the issued and outstanding Common Stock. The Armada Note contains certain representations, warranties, covenants and events of default including if the Common Stock is suspended or delisted for trading on the OTC Marketplace or if the Company is delinquent in its periodic report filings with the SEC. In the event of default, as described in the Armada Note, at the option of Armada, it may consider the Armada Note immediately due and payable. The Company recorded an original issue discount in the amount of $3,000 in connection with the Armada Note; $255 was amortized to interest expense during the six months needed June 30, 2019. The Company accrued interest in the amount of $253 on the Armada Note during the six months ended June 30, 2019. The principal balance under this note was $38,500 at June 30, 2019.

XML

Note 6 - Stockholders' Deficit

6 Months Ended

Jun. 30, 2019

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

Note 6 – Stockholders’ Deficit

Shares for Stock Based Compensation

During the six months ending June 30, 2019, the Company issued 200,000 restricted shares of the Company’s common stock at valued $17,480 in exchange for services conducted on behalf of the Company. The value of these shares was based on the closing market price on the respective date of grant.  Also during the six months ended June 30, 2019, the Company issued 1,000,000 shares of common stock to employees, subject to vesting provisions, pursuant to employment agreements. The par value of these shares in the amount of $10,000 was credited to paid-in capital. During the six months ended June 30, 2019, the Company charged the amount of $25,093 to paid-in capital representing the vesting of shares issued to employees. 

During the six months ending June 30, 2018, the Company issued 800,000 restricted shares of the Company’s common stock at valued $40,120 in exchange for reimbursement of expenses paid on behalf of the Company and for services provided. The value of these shares was based on the closing market price on the respective date of grant.

Stock-based compensation expenses are included in general and administrative expenses on the condensed consolidated statements of operations.

Shares issued for notes payable

During the six months ended June 30, 2019, the Company issued, in 13 transactions, a total of 5,278,069 shares in connection with the conversion of notes payable principal and accrued interest in the aggregate amount of $177,365 and $19,385, respectively; a loss in the aggregate amount of $158,659 was recognized on these transactions (see note 5).

During the six months ending June 30, 2018, the Company issued 75,000 restricted shares of common stock valued at $7,500 for an extension of the term of a note payable.  

Shares issued for conversion of accounts payable

During the six months ended June 30, 2019, the Company did not issue any shares to settle accounts payable.

During the six months ending June 30, 2018, the Company issued 4,405,123 shares valued at $432,733 to settle outstanding accounts payable.  There was a loss on the transaction of $36,100 because the fair value of the issuance exceeded the fair value of the accounts payable settled.

Stock returned for cancellation

During the six months ended June 30, 2019, the Company cancelled 400,000 shares of common stock issued to a former executive officer.

During the six months ended June, 2018. there were no cancellations of common stock.

Shares issued for legal settlement

During the six months ended June 30, 2019, the Company issued 1,401,224 shares of common stock in connection with the settlement of a note payable in the amount of $74,104. The Company recorded a loss in the amount of $26,924 in connection with this transaction.

During the six months ended June, 2018. there were no shares issued in connection with a legal settlement.

XML

Note 7 - Stock Options

6 Months Ended

Jun. 30, 2019

Share-based Payment Arrangement [Abstract]

Share-based Payment Arrangement [Text Block]

Note 7 – Stock Options

A summary of options issued, exercised and cancelled are as follows:

	Shares		Weighted- Average Exercise Price ($)		Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value ($)
Outstanding at December 31, 2017		67,879	$	21.40		5.17	$	-
Granted		-		-		-		-
Cancelled		-		-		-		-
Outstanding at December 31, 2018		67,879	$	21.40		4.17		-
Granted		-		-		-		-
Cancelled		-		-		-		-
Outstanding at June 30, 2019		67,879	$	21.40		3.67	$	-
Exercisable at June 30, 2019		67,879	$	21.40		3.67	$	-

XML

Note 8 - Stock Warrants

6 Months Ended

Jun. 30, 2019

Disclosure Text Block Supplement [Abstract]

Shareholders' Equity and Share-based Payments [Text Block]

Note 8 – Stock Warrants

A summary of warrants issued, exercised and expired are as follows:

	Shares			Weighted- Average Exercise Price ($)		Weighted- Average Remaining Contractual Term
Outstanding at December 31, 2017		142,653		$	17.42		1.00
Granted		1,025,000			0.10		4.93
Expired		-			-		-
Outstanding at December 31, 2018		1,167,653		$	2.18		4.36
Granted		400,000			0.10		4.50
Expired		(142,653	)		17.42		-
Outstanding at June 30, 2019		1,425,000		$	0.10		4.50
Exercisable at June 30, 2019		1,425,000		$	0.10		4.50

XML

Note 9 - Commitments and Contingencies

6 Months Ended

Jun. 30, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

Note 9 – Commitments and Contingencies

Legal

Stress Free Capital, Inc. vs. True Nature Holdings, Inc. Case No. CACE-18-0108656

Pursuant to a judgment rendered in the Seventeenth Judicial District I and for Broward County, Florida, the Company in June 2019 issued 1,401,224 shares of common stock in complete settlement of a note payable to the plaintiff in the aggregate amount of $84,073.48.

National Council for Science and the Environment, Inc. v. Trunity Holdings, Inc., Case No. 2015 CA 009726 B, Superior Court for the District of Columbia, Civil Division.

This action was filed on December 16, 2015 by the National Council for Science and the Environment, Inc. (“NCSE”) in the state court in the District of Columbia against Trunity Holdings, Inc. (“Trunity”) and alleges claims for breach of contract. Acknowledgement of indebtedness and settlement agreement and quantum meruit arising out of an agreement entered into between NCSE and Trunity in 2014. The complaint seeks damages in the amount of $177,270, inclusive of attorney’s fees, costs and accrued interest, continuing interest in the amount of 12% per annum and attorney’s fees and costs of collection relating to the case. The Company, in its answer dated January 27, 2016, denied the material allegations made by NCSE, asserted a number of affirmative defenses and filed a counterclaim alleging claims for fraud, negligent misrepresentation, breach of fiduciary duty, breach of contract and unjust enrichment. In its counterclaim, the Company sought actual and compensatory damages against NCSE that it believes exceed the amount sought by NCSE on its claims, pre-judgment interest, punitive damages and all costs and expenses, including attorney’s fees, incurred by the Company in bringing its claims against NCSE.

On September 23, 2016, the Company settled this obligation with an agreement to pay $48,500 to NCSE if paid by November 4, 2016, and $75,000 if paid later. The Company has not paid the amounts as of the date of this filing and has recorded the obligation at $75,000.

Carlton Fields Jorden Burt, P.A.

This action was filed on May 18, 2017 by a law firm that represented the Company prior to the spin-out of the educational software business in 2016 with the intent of collection past due invoices in the aggregate amount of $241,828.  The Company believes it has strong defenses against any such action and anticipates a settlement upon completion of certain funding activities. The Company has recorded a liability in the amount of $241,828 on its balance sheet at December 31, 2018. The Company has negotiated a settlement to this claim subject to funding.

Trunity, Inc.

The spin-out that now owns the former educational software business has been informed that they owe the Company from the obligations of the NCSE settlement, and the costs of the legal action. We intend to take all actions available to us to collect on these amounts.

Randstad General Partner (US) LLC D/B/A Tatum

A former service provider of the Company has filed an action in Georgia to collect the amount of $44,365 for services provided to the Company. On October 18, 2018, the Superior Court of Fulton County, State of George issued an Order & Final Judgment against the Company in the amount of $44,365 plus an additional $11,001 of accrued interest. The Company has accrued the amount of $55,366 on its balance sheet at June 30, 2019 in connection with this claim. On July 3, 2019 the Company settled this matter with a $5,000 payment made by a shareholder for the benefit of the Company.

XML

Note 10 - Subsequent Events

6 Months Ended

Jun. 30, 2019

Subsequent Events [Abstract]

Subsequent Events [Text Block]

Note 10 – Subsequent Events

In July 2019, the Company received funds of approximately $36,000 pursuant to Crown Bridge Note 3. Crown Bridge Note 3 is a convertible promissory note in the amount of $40,000 with an original issue discount of $4,000. Crown Bridge Note 3 bears interest at the rate of 12% per year and becomes convertible at any time following the 180^th calendar day after the issue date at a price per share equal to 55% of the lowest trading price for the Company’s common stock for the twenty-five days prior to the conversion date. The Crown Bridge Note 3 is due April 2, 2020.

In July 2019, the Company received funds of approximately $35,000 pursuant to Power Up Note 10. Power Up Note 10 is a convertible promissory note in the amount of $38,000 with an original issue discount of $3,000. Power Up Note 10 bears interest at the rate of 12% per year and becomes convertible at any time following the 180^th calendar day after the issue date at a price per share equal to 55% of the lowest trading price for the Company’s common stock for the twenty-five days prior to the conversion date.  The Power Up Note 10  is due April 30, 2020.

In July 2019, the Company issued 377,834 shares of common stock in connection with the conversion of $15,000 of principle due under the Power Up Note 5.

In July 2019, the Company issued 523,560 shares of common stock in connection with the conversion of $20,000 of principle due under the Power Up Note 5.

In July 2019, the Company issued 586,704 shares of common stock in connection with the conversion of $18,000 of principle due under the Power Up Note 5.

In July 2019, the Company issued 360,000 shares of common stock in connection with the conversion of $10,197 of principle due under the Crown Bridge Note 1.

In July 2019, the Company cancelled 300,000 shares of common stock held by its previous Chief Executive Officer.

In August 2019, the Company issued 1,000,000 shares of common stock in connection with the conversion of $29,050 of principal due under the Auctus Note.

XML

Accounting Policies, by Policy (Policies)

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Accounting – The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to interim financial reporting as prescribed by the Securities and Exchange Commission (the “SEC”). The results for the interim periods are not necessarily indicative of results for the entire year. These interim financial statements do not include all disclosures required by U.S. generally accepted accounting principles (“GAAP”), and should be read in conjunction with the consolidated financial statements and notes thereto filed with the SEC in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018. In the opinion of management, the unaudited Condensed Consolidated Financial Statements contained in this report include all known accruals and adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows for the periods reported herein. Any such adjustments are of a normal recurring nature.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates - The preparation of these financial statements requires our management to make estimates and assumptions about future events that affect the amounts reported in the financial statements and related notes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment.

Comprehensive Income, Policy [Policy Text Block]

Comprehensive Loss – Comprehensive income (loss) as defined includes all changes in equity during a period from non-owner sources. Items included in the Company’s comprehensive loss consist of unrealized gains (losses) on securities.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash -All highly liquid investments with a maturity date of three months or less at the date of purchase are cash equivalents.

Revenue [Policy Text Block]

Revenue Recognition – On January 1, 2018, we adopted Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (ASC) Topic 605, Revenue Recognition (Topic 605). Results for reporting periods beginning after January 1, 2018 are presented under Topic 606. The impact of adopting the new revenue standard was not material to our financial statements and there was no adjustment to beginning retained earnings on January 1, 2018.

Under Topic 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services.

We determine revenue recognition through the following steps:

● identification of the contract, or contracts, with a customer;

● identification of the performance obligations in the contract;

● determination of the transaction price;

● allocation of the transaction price to the performance obligations in the contract; and

● recognition of revenue when, or as, we satisfy a performance obligation.

Share-based Payment Arrangement [Policy Text Block]

Stock-Based Compensation-We recognize the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation cost for stock options are estimated at the grant date based on each option’s fair-value as calculated by the Black-Scholes-Merton (“BSM”) option-pricing model. Share-based compensation arrangements may include stock options, restricted share plans, performance-based awards, share appreciation rights and employee share purchase plans. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.

Equity instruments issued to those other than employees are recorded on the basis of the fair value of the instruments. In general, the measurement date is when either a (a) performance commitment, as defined, is reached or (b) the earlier of (i) the non-employee performance is complete or (ii) the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances of each particular grant.

Convertible Instruments, Policy [Policy Text Block]

Convertible Instruments-The Company reviews the terms of convertible debt and equity instruments to determine whether there are conversion features or embedded derivative instruments including embedded conversion options that are required to be bifurcated and accounted for separately as a derivative financial instrument. In circumstances where the convertible instrument contains more than one embedded derivative instrument, including conversion options that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single compound instrument. Also, in connection with the sale of convertible debt and equity instruments, the Company may issue free standing warrants that may, depending on their terms, be accounted for as derivative instrument liabilities, rather than as equity. When convertible debt or equity instruments contain embedded derivative instruments that are to be bifurcated and accounted for separately, the total proceeds allocated to the convertible host instruments are first allocated to the fair value of the bifurcated derivative instrument. The remaining proceeds, if any, are then allocated to the convertible instruments themselves, usually resulting in those instruments being recorded at a discount from their face amount. When the Company issues debt securities, which bear interest at rates that are lower than market rates, the Company recognizes a discount, which is offset against the carrying value of the debt. Such discount from the face value of the debt, together with the stated interest on the instrument, is amortized over the life of the instrument through periodic charges to income. In addition, certain conversion features are recognized as beneficial conversion features to the extent the conversion price as defined in the convertible note is less than the closing stock price on the issuance of the convertible notes.

Warrants, Policy [Policy Text Block]

Common Stock Purchase Warrants-The Company accounts for common stock purchase warrants in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 815, Accounting for Derivative Instruments and Hedging Activities. As is consistent with its handling of stock compensation and embedded derivative instruments, the Company’s cost for stock warrants is estimated at the grant date based on each warrant’s fair-value as calculated by the BSM option-pricing model value method for valuing the impact of the expense associated with these warrants.

Stockholders' Equity, Policy [Policy Text Block]

Stockholders’ Equity-Shares of common stock issued for other than cash have been assigned amounts equivalent to the fair value of the service or assets received in exchange. Common stock share and per share amounts in these financial statements have been adjusted for the effects of a one for 101 reverse stock split that occurred in January 2016.

Earnings Per Share, Policy [Policy Text Block]

Per Share Data-Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the year. Diluted loss per share is computed by dividing net loss by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to warrants, options and convertible instruments.

The Company has excluded all common equivalent shares outstanding for warrants, options and convertible instruments to purchase common stock from the calculation of diluted net loss per share because all such securities are anti-dilutive for the periods presented. As of June 30, 2019, the Company had outstanding 1,425,000 warrants and 67,879 options excluded from the calculation of diluted net loss; as of December 31, 2018, the Company had outstanding 1,167,653 warrants and 67,879 options excluded from the calculation of diluted net loss.

Income Tax, Policy [Policy Text Block]

Income Taxes- The Company accounts for income taxes under the asset and liability method which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s condensed consolidated financial statements or tax returns. In estimating future tax consequences, the Company generally considers all expected future events other than possible enactments of changes in the tax laws or rates.

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses, the sale of profitable divisions and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance.  The following table reflects the deferred tax asset balance at June 30, 2019:

	June 30, 2019
Deferred tax Asset		718,332
Less: valuation allowance		(718,332	)
Net deferred tax asset		-

The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the condensed consolidated financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is generally no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012.

Business Combinations Policy [Policy Text Block]

Business Combinations- The Company accounts for business combinations by recognizing the assets acquired, liabilities assumed, contractual contingencies, and contingent consideration at their fair values on the acquisition date. The purchase price allocation process requires management to make significant estimates and assumptions, especially with respect to intangible assets, estimated contingent consideration payments and pre-acquisition contingencies. Examples of critical estimates in valuing certain of the intangible assets we have acquired or may acquire in the future include but are not limited to:

● future expected cash flows from product sales, support agreements, consulting contracts, other customer contracts, and acquired developed technologies and patents; and

● discount rates utilized in valuation estimates.

Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions, estimates or actual results. Additionally, any change in the fair value of the acquisition-related contingent consideration subsequent to the acquisition date, including changes from events after the acquisition date, such as changes in our estimates of relevant revenue or other targets, will be recognized in earnings in the period of the estimated fair value change. A change in fair value of the acquisition-related contingent consideration or the occurrence of events that cause results to differ from our estimates or assumptions could have a material effect on the condensed consolidated financial position, statements of operations or cash flows in the period of the change in the estimate.

Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]

Impairment of Long-Lived Assets-Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed would be separately presented in the condensed consolidated balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and are no longer depreciated. The assets and liabilities of a disposal group classified as held-for-sale would be presented separately in the appropriate asset and liability sections of the condensed consolidated balance sheet, if material. No impairment losses have been realized for the periods presented.

Fair Value of Financial Instruments, Policy [Policy Text Block]

Financial Instruments and Fair Values-The fair value of a financial instrument represents the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. Fair value estimates are made at a specific point in time, based upon relevant market information about the financial instrument. In determining fair value, we use various valuation methodologies and prioritize the use of observable inputs. We assess the inputs used to measure fair value using a three-tier hierarchy based on the extent to which inputs used in measuring fair value are observable in the market:

Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable.

Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates.

Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability.

The use of observable and unobservable inputs and their significant in measuring fair value are reflected in our hierarchy assessment. The carrying amount of cash, prepaid assets, accounts payable and accrued liabilities approximates fair value due to the short-term maturities of these instruments. Because cash and cash equivalents are readily liquidated, management classifies these values as Level 1. The fair value of the debentures, approximate their book value as the instruments are short-term in nature and contain market rates of interest. Because there is no ready market or observable transactions, management classifies the debentures as Level 3.

New Accounting Pronouncements, Policy [Policy Text Block]

Recently Issued Accounting Standards-There are various other updates recently issued, most of which represent technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s condensed consolidated financial position, results of operations or cash flows.

XML

Note 2 - Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2019

Accounting Policies [Abstract]

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses, the sale of profitable divisions and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance. The following table reflects the deferred tax asset balance at June 30, 2019:

	June 30, 2019
Deferred tax Asset		718,332
Less: valuation allowance		(718,332	)
Net deferred tax asset		-

XML

Note 7 - Stock Options (Tables)

6 Months Ended

Jun. 30, 2019

Share-based Payment Arrangement [Abstract]

Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of options issued, exercised and cancelled are as follows:

	Shares		Weighted- Average Exercise Price ($)		Weighted- Average Remaining Contractual Term		Aggregate Intrinsic Value ($)
Outstanding at December 31, 2017		67,879	$	21.40		5.17	$	-
Granted		-		-		-		-
Cancelled		-		-		-		-
Outstanding at December 31, 2018		67,879	$	21.40		4.17		-
Granted		-		-		-		-
Cancelled		-		-		-		-
Outstanding at June 30, 2019		67,879	$	21.40		3.67	$	-
Exercisable at June 30, 2019		67,879	$	21.40		3.67	$	-

XML

Note 8 - Stock Warrants (Tables)

6 Months Ended

Jun. 30, 2019

Disclosure Text Block Supplement [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of warrants issued, exercised and expired are as follows:

	Shares			Weighted- Average Exercise Price ($)		Weighted- Average Remaining Contractual Term
Outstanding at December 31, 2017		142,653		$	17.42		1.00
Granted		1,025,000			0.10		4.93
Expired		-			-		-
Outstanding at December 31, 2018		1,167,653		$	2.18		4.36
Granted		400,000			0.10		4.50
Expired		(142,653	)		17.42		-
Outstanding at June 30, 2019		1,425,000		$	0.10		4.50
Exercisable at June 30, 2019		1,425,000		$	0.10		4.50

XML

Note 2 - Summary of Significant Accounting Policies (Details) - shares		6 Months Ended	12 Months Ended
	Jan. 16, 2016	Jun. 30, 2019	Dec. 31, 2018
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Stockholders' Equity, Reverse Stock Split	one for 101
Warrant [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		1,425,000	1,167,653
Share-based Payment Arrangement, Option [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount		67,879	67,879

XML

Note 2 - Summary of Significant Accounting Policies (Details) - Schedule of Deferred Tax Assets and Liabilities	Jun. 30, 2019 USD ($)
Schedule of Deferred Tax Assets and Liabilities [Abstract]
Deferred tax Asset	$ 718,332
Less: valuation allowance	(718,332)
Net deferred tax asset	$ 0

XML

Note 3 - Financial Condition and Going Concern (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018	Jun. 30, 2018	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and Cash Equivalents, at Carrying Value	$ 284	$ 1,304	$ 1,108	$ 0
Liabilities, Current	$ 1,851,108	$ 1,534,740

XML

Note 4 - Related Party Transactions (Details) - USD ($)						3 Months Ended		6 Months Ended
	Mar. 11, 2019	Jun. 14, 2018	Jun. 13, 2018	Apr. 23, 2018	Jan. 29, 2018	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018	Jul. 10, 2017
Note 4 - Related Party Transactions (Details) [Line Items]
Stock Issued During Period, Value, Issued for Services							$ 245,580	$ 17,480	$ 248,765
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition								25,093
Due to Officers or Stockholders, Current						$ 50,099		50,099
Accounts Payable, Related Parties						58,000		58,000
Debt Conversion, Original Debt, Amount								$ 74,104
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								1,401,224
Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture							13,740		153,873
Share-based Payment Arrangement, Noncash Expense								$ 42,573	47,620
Gain (Loss) on Extinguishment of Debt						(26,924)	0	(26,924)	0
President [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services (in Shares)	100,000
Stock Issued During Period, Value, Issued for Services	$ 8,740
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition								2,875
Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture (in Shares)			100,000	500,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights				(i) 100,000 shares vest when the President has been employed 90 days from the effective date of the employment agreement; (ii) 100,000 shares vest when the President has been employed one year from the effective date of the employment agreement; (iii) 100,000 shares vest when the President has been employed two years from the effective date of the employment agreement; (iv) 100,000 shares vest when the Company completes a capital raise of $2,000,000; (v) 100,000 shares vest when the Company reports $20,000,000 in gross revenue
Shares Issued, Price Per Share (in Dollars per share)				$ 0.10
Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture			$ 8,380	$ 50,000
Share-based Payment Arrangement, Noncash Expense							13,740
Board Member [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services (in Shares)	100,000
Stock Issued During Period, Value, Issued for Services	$ 8,740
Officer [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Original Debt, Amount					$ 93,333
Increase (Decrease) in Accrued Salaries									50,000
Interest Expense, Related Party									4,500
Debt Instrument, Face Amount							$ 75,000		$ 75,000
Officer [Member] | Restricted Stock [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)					897,432
Debt Conversion, Converted Instrument, Amount					$ 93,333
Board of Directors Chairman [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture (in Shares)		100,000
Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture		$ 9,000
Director [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture (in Shares)		100,000
Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture		$ 9,000
July 2017 Note [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Notes Payable, Related Parties						75,000		75,000
Debt Instrument, Face Amount											$ 75,000
ConsultingServices Note [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Notes Payable, Related Parties						$ 65,000		65,000
Debt Instrument, Face Amount										$ 65,000
Accounts Payable [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Original Debt, Amount				$ 96,000				$ 432,733
Debt Conversion, Converted Instrument, Shares Issued (in Shares)								4,405,123
Gain (Loss) on Extinguishment of Debt								$ 36,100
Accounts Payable [Member] | Investor [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Original Debt, Amount					$ 54,815
Debt Conversion, Converted Instrument, Shares Issued (in Shares)				600,000
Debt Conversion, Converted Instrument, Amount				$ 48,000
Accounts Payable [Member] | Investor [Member] | Restricted Stock [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)					527,064
Debt Conversion, Converted Instrument, Amount					$ 54,815
Accounts Payable [Member] | Affiliated Entity [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)				600,000
Debt Conversion, Converted Instrument, Amount				$ 48,000
Accrued Expenses Paid on Behalf of Company [Member] | Investor [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Original Debt, Amount		60,000
Gain (Loss) on Extinguishment of Debt		$ (35,700)
Accrued Expenses Paid on Behalf of Company [Member] | Investor [Member] | Restricted Stock [Member]
Note 4 - Related Party Transactions (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		1,100,000
Debt Conversion, Converted Instrument, Amount		$ 95,700

XML

Note 5 - Debt (Details) - USD ($)																													1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 17, 2019	Jun. 10, 2019	Jun. 04, 2019	May 25, 2019	May 08, 2019	May 02, 2019	Apr. 01, 2019	Mar. 18, 2019	Mar. 17, 2019	Mar. 04, 2019	Feb. 11, 2019	Jan. 02, 2019	Jan. 01, 2019	Dec. 19, 2018	Nov. 26, 2018	Nov. 09, 2018	Sep. 18, 2018	Aug. 13, 2018	Aug. 10, 2018	Jul. 26, 2018	Jul. 05, 2018	Aug. 10, 2017	Jul. 10, 2017	Dec. 30, 2016	Sep. 19, 2016	Mar. 18, 2016	Nov. 30, 2014	Aug. 31, 2014	Apr. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018	Dec. 31, 2016
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																																1,401,224
Stock Issued During Period, Value, Conversion of Convertible Securities																														$ 165,425		$ 355,409	$ 54,815
Debt Conversion, Original Debt, Amount																																74,104
Gain (Loss) on Extinguishment of Debt																														(26,924)	$ 0	(26,924)	0
Convertible Notes Payable																														0		0
Debt Instrument, Unamortized Discount																														117,198		117,198		$ 86,520
Debt Instrument, Convertible, Beneficial Conversion Feature																																223,087	0
Amortization of Debt Discount (Premium)																																$ 261,035	0
Class of Warrant or Rights, Granted (in Shares)																																400,000		1,025,000
Stock Issued During Period, Value, Issued for Services																															$ 245,580	$ 17,480	$ 248,765
P3 Compounding of Georgia, LLC [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																																			$ 52,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																																1,401,224
Debt Conversion, Original Debt, Amount																																$ 74,104
Gain (Loss) on Extinguishment of Debt																																$ (16,955)
Debt Instrument, Periodic Payment																								$ 451.75
Debt Instrument, Frequency of Periodic Payment																								repayment amount of $451.75 per day
Debt Instrument, Unamortized Discount																																			22,280
Amortization of Debt Discount (Premium)																																			22,280
Debt Instrument, Interest Rate, Stated Percentage																								10.50%
Proceeds from Short-term Debt																								$ 50,000
Debt Instrument, Fee Amount																								$ 2,000
Debt Instrument, Term																								160 days
Convertible Note A [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																										$ 60,000
Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)																									15,000	15,000
Shares Issued, Price Per Share (in Dollars per share)																									$ 0.30
Stock Issued During Period, Value, Restricted Stock Award, Gross																									$ 4,050
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																						25,000										120,000
Stock Issued During Period, Value, Conversion of Convertible Securities																						$ 3,750
Debt Conversion, Original Debt, Type of Debt																						accrued interest
Debt Conversion, Original Debt, Amount																						$ 7,860										$ 15,000
Stock Issued During Period, Shares, New Issues (in Shares)																		75,000											75,000
Stock Issued During Period, Value, New Issues																		$ 6,750											$ 7,500
Gain (Loss) on Extinguishment of Debt																																(13,867)
Debt Instrument, Increase, Accrued Interest																																2,900
Convertible Notes Payable																														45,000		45,000
Interest Payable																														4,379		4,379
Debt Instrument, Periodic Payment																										$ 1,000
Debt Instrument, Frequency of Periodic Payment																										first of each month commencing the month
Debt Instrument, Convertible, Terms of Conversion Feature																										The Convertible Note A is convertible by the holder at any time into shares of the Company’s common stock at price of $1.00 per share, and throughout the duration of the note, the holder has the right to participate in any financing the Company may engage in upon the same terms and conditions as all other investors.
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																										$ 1.00
Debt Instrument, Unamortized Discount																										$ 18,750
Debt Instrument, Convertible, Beneficial Conversion Feature																										$ 9,375
Amortization of Debt Discount (Premium)																																0			$ 28,125
Series C Debenture [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																												$ 100,000
Debt Instrument, Increase, Accrued Interest																																5,534
Interest Payable																														52,121		52,121		$ 46,587
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																												$ 20.20
Convertible Debt																												$ 110,833		110,833		110,833
Debt Instrument, Interest Rate, Stated Percentage																												10.00%
Class of Warrant or Rights, Granted (in Shares)																												4,950
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																												$ 20.20
Series D Debenture [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																											$ 10,000
Debt Instrument, Increase, Accrued Interest																																679
Interest Payable																														6,340		6,340		5,661
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																											$ 16.67
Convertible Debt																											$ 11,333			11,333		11,333
Debt Instrument, Interest Rate, Stated Percentage																											12.00%
Class of Warrant or Rights, Granted (in Shares)																											495
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)																											$ 20.20
July 2017 Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																							$ 75,000
Debt Instrument, Interest Rate, Stated Percentage																							12.00%
Debt Instrument, Maturity Date, Description																							The July 2017 Note is due no later than 90 days after the receipt of a minimum of $1,000,000 of funding.
Interest Expense, Debt																																$ 4,500
July 2018 RU Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																				$ 30,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																																400,000
Gain (Loss) on Extinguishment of Debt																																$ (2,637)
Debt Instrument, Increase, Accrued Interest																																1,776
Debt Instrument, Interest Rate, Stated Percentage																				12.00%
Debt Instrument, Term																				6 months
Stock Issued During Period, Shares, Issued for Services (in Shares)																				250,000
Stock Issued During Period, Value, Issued for Services																				$ 20,000
Notes Payable																														0		0
Power Up Note 1 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																					$ 38,000
Debt Instrument, Increase, Accrued Interest																																58
Convertible Notes Payable																														0		0
Debt Instrument, Convertible, Terms of Conversion Feature																					Under the Power Up Note 1, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 1 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 1, at a price equal to 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, but no lower than $0.00006 (fixed price floor), provided, however, that Power Up may not convert the Power Up Note 1 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																					$ 0.00006
Debt Instrument, Unamortized Discount																					$ 3,000
Debt Instrument, Convertible, Beneficial Conversion Feature													$ 9,032
Amortization of Debt Discount (Premium)																																2,077
Debt Instrument, Interest Rate, Stated Percentage																					12.00%
Debt Instrument, Fee Amount																														16,072		16,072
Interest Expense, Debt																																$ 9,032
Debt Instrument, Payment Terms																					If the Company prepays the Power Up Note 1 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 1, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 1, there shall be no further right of prepayment
Debt Instrument, Fee																																prepayment penalty
Power Up Note 2 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																			$ 33,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																																624,993
Gain (Loss) on Extinguishment of Debt																																$ (34,101)
Debt Instrument, Increase, Accrued Interest																																418
Convertible Notes Payable																														0		0
Debt Instrument, Convertible, Terms of Conversion Feature																			Under the Power Up Note 2, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 2 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 2, at a price equal to 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, but no lower than $0.00006 (fixed price floor), provided, however, that Power Up may not convert the Power Up Note 2 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																			$ 0.00006
Debt Instrument, Unamortized Discount																														32,500		32,500
Debt Instrument, Convertible, Beneficial Conversion Feature																			$ 3,000
Amortization of Debt Discount (Premium)																																3,000
Debt Instrument, Interest Rate, Stated Percentage																			12.00%
Debt Instrument, Payment Terms																			If the Company prepays the Power Up Note 2 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 2, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note, there shall be no further right of prepayment
Power Up Note 3 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																	$ 38,000
Debt Conversion, Original Debt, Amount																																1,173,632
Gain (Loss) on Extinguishment of Debt																																(45,724)
Debt Instrument, Increase, Accrued Interest																																1,592
Convertible Notes Payable																														0		0
Debt Instrument, Convertible, Terms of Conversion Feature																	Under the Power Up Note 3, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 3 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 3, at a price equal to 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, but no lower than $0.00006 (fixed price floor), provided, however, that Power Up may not convert the Power Up Note 3 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																	$ 0.00006
Debt Instrument, Convertible, Beneficial Conversion Feature									$ 38,000								$ 3,000
Amortization of Debt Discount (Premium)									$ 38,000																							$ 3,000
Debt Instrument, Interest Rate, Stated Percentage																	12.00%
Debt Instrument, Payment Terms																	If the Company prepays the Power Up Note 3 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 3, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 3, there shall be no further right of prepayment
Power Up Note 4 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																$ 33,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																																1,619,444
Gain (Loss) on Extinguishment of Debt																																$ (63,443)
Debt Instrument, Increase, Accrued Interest																																976
Convertible Notes Payable																														0		0
Debt Instrument, Convertible, Terms of Conversion Feature																Under the Power Up Note 4, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 4 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 4, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 4 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Convertible, Beneficial Conversion Feature					$ 33,000											$ 3,000
Amortization of Debt Discount (Premium)					$ 33,000																											$ 3,000
Debt Instrument, Interest Rate, Stated Percentage																12.00%
Debt Instrument, Payment Terms																If the Company prepays the Power Up Note 4 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 4, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 4, there shall be no further right of prepayment.
Power Up Note 4 [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)																$ 0.00006
Autus Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount															$ 125,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																																1,000,000
Gain (Loss) on Extinguishment of Debt																																$ (1,291)
Debt Instrument, Increase, Accrued Interest																																7,393
Convertible Notes Payable																														101,791		101,791
Debt Instrument, Convertible, Terms of Conversion Feature															The variable conversion price shall mean 55% of the lowest trading price during the 25 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Auctus may not convert the Auctus Note to the extent that such conversion would result in beneficial ownership by Auctus and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Convertible, Beneficial Conversion Feature				$ 125,000											$ 13,500
Amortization of Debt Discount (Premium)				$ 31,079																												$ 8,951
Debt Instrument, Interest Rate, Stated Percentage															12.00%
Class of Warrant or Rights, Granted (in Shares)															625,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)															$ 0.10
Debt Instrument, Payment Terms															If the Company prepays the Auctus Note within 90 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 135%; if such prepayment is made between the 91st day and the 180th day after the issuance of the Auctus Note, then such redemption premium is 150%. After the 180th day following the issuance of the Auctus Note, there shall be no further right of prepayment.
Warrants and Rights Outstanding, Term															5 years
Warrants, Fair Value of Warrants, Granted															$ 39,595
Adjustments to Additional Paid in Capital, Warrant Issued															$ 26,251
Autus Note [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)															$ 0.00003
Crown Bridge Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount														$ 40,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)																																340,000
Debt Conversion, Original Debt, Amount																																$ 9,598
Gain (Loss) on Extinguishment of Debt																																2,881
Debt Instrument, Increase, Accrued Interest																																		2,381
Convertible Notes Payable																														30,402		30,402
Debt Instrument, Convertible, Beneficial Conversion Feature	$ 40,000													$ 5,500
Amortization of Debt Discount (Premium)	$ 17,961																															3,634
Debt Instrument, Interest Rate, Stated Percentage														12.00%
Class of Warrant or Rights, Granted (in Shares)														400,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)														$ 0.10
Debt Instrument, Payment Terms														If the Company prepays the Crown Bridge Note 1 within 90 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 135%; if such prepayment is made between the 91st day and the 180th day after the issuance of the Crown Bridge Note 1, then such redemption premium is 150%. After the 180th day following the issuance of the Crown Bridge Note 1, there shall be no further right of prepayment.
Warrants and Rights Outstanding, Term														5 years
Warrants, Fair Value of Warrants, Granted														$ 34,500
Adjustments to Additional Paid in Capital, Warrant Issued																																22,790
Crown Bridge Note [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)														$ 0.00006
ConsultingServices Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																																		$ 65,000
Debt Instrument, Increase, Accrued Interest																																3,868
Debt Instrument, Interest Rate, Stated Percentage																																		12.00%
Notes Payable																														65,000		65,000
Trade Payables Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount																																		$ 58,000
Debt Instrument, Increase, Accrued Interest																																3,451
Debt Instrument, Interest Rate, Stated Percentage																																		12.00%
Notes Payable																														58,000		58,000
Long-term Debt, Maturity Date																																		Mar. 21, 2020
Power Up Note 5 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount												$ 53,000
Debt Instrument, Increase, Accrued Interest																																3,119
Convertible Notes Payable																														53,000		53,000
Debt Instrument, Convertible, Terms of Conversion Feature												Under the Power Up Note 5, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 5 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 5, at a price equal to the higher of the variable conversion price or $0.00006 per share. The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 5 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock
Debt Instrument, Convertible, Beneficial Conversion Feature												$ 3,000
Amortization of Debt Discount (Premium)																																2,238
Debt Instrument, Interest Rate, Stated Percentage												12.00%
Debt Instrument, Payment Terms												If the Company prepays the Power Up Note 5 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 5, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 5, there shall be no further right of prepayment
Power Up Note 5 [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)												$ 0.00006
Power Up Note 6 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount											$ 48,000
Debt Instrument, Increase, Accrued Interest																																1,598
Convertible Notes Payable																														48,000		48,000
Debt Instrument, Convertible, Terms of Conversion Feature											Under the Power Up Note 6, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 6 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 6, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 6 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Convertible, Beneficial Conversion Feature											$ 3,000
Amortization of Debt Discount (Premium)																																1,598
Debt Instrument, Interest Rate, Stated Percentage											12.00%
Debt Instrument, Payment Terms											If the Company prepays the Power Up Note 6 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 6, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 6, there shall be no further right of prepayment.
Power Up Note 6 [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)											$ 0.00006
Crown Bridge Note 2 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount										$ 40,000
Debt Instrument, Increase, Accrued Interest																																2,761
Debt Instrument, Unamortized Discount										$ 5,500
Amortization of Debt Discount (Premium)																																2,360
Convertible Debt																														40,000		40,000
Debt Instrument, Interest Rate, Stated Percentage										12.00%
Class of Warrant or Rights, Granted (in Shares)										400,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)										$ 0.10
Debt Instrument, Payment Terms										If the Company prepays the Crown Bridge Note 2 within 90 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 135%; if such prepayment is made between the 91st day and the 180th day after the issuance of the Crown Bridge Note 2, then such redemption premium is 150%. After the 180th day following the issuance of the Crown Bridge Note 2, there shall be no further right of prepayment.
Warrants and Rights Outstanding, Term										5 years
Warrants, Fair Value of Warrants, Granted										$ 34,500
Adjustments to Additional Paid in Capital, Warrant Issued										$ 14,803
Crown Bridge Note 2 [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)										$ 0.00003
Power Up Note 7 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount								$ 43,000
Debt Instrument, Increase, Accrued Interest																																1,456
Convertible Notes Payable																														43,000		43,000
Debt Instrument, Convertible, Terms of Conversion Feature								Under the Power Up Note 7, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 7 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 7, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 7 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Convertible, Beneficial Conversion Feature								$ 3,000
Amortization of Debt Discount (Premium)																																981
Debt Instrument, Interest Rate, Stated Percentage								12.00%
Debt Instrument, Payment Terms								If the Company prepays the Power Up Note 7 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 7, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 7, there shall be no further right of prepayment.
Power Up Note 7 [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)								$ 0.00006
Power Up Note 8 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount							$ 53,000
Debt Instrument, Increase, Accrued Interest																																1,586
Convertible Notes Payable																														53,000		53,000
Debt Instrument, Convertible, Terms of Conversion Feature							Under the Power Up Note 8, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 8 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 8, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 8 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Convertible, Beneficial Conversion Feature							$ 3,000
Amortization of Debt Discount (Premium)																																883
Debt Instrument, Interest Rate, Stated Percentage							12.00%
Debt Instrument, Payment Terms							If the Company prepays the Power Up Note 8 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 8, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 8, there shall be no further right of prepayment.
Power Up Note 8 [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)							$ 0.00006
Power Up Note 9 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount						$ 33,000
Debt Instrument, Increase, Accrued Interest																																662
Convertible Notes Payable																														33,000		33,000
Debt Instrument, Convertible, Terms of Conversion Feature						Under the Power Up Note 9, Power Up may convert all or a portion of the outstanding principal of the Power Up Note 9 into shares of Common Stock beginning on the date which is 180 days from the issuance date of the Power Up Note 9, at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price  shall mean 61% of the average of the lowest two trading prices during the 15 trading day period ending on the last complete trading date prior to the date of conversion, provided, however, that Power Up may not convert the Power Up Note 9 to the extent that such conversion would result in beneficial ownership by Power Up and its affiliates of more than 4.99% of the Company’s issued and outstanding Common Stock.
Debt Instrument, Convertible, Beneficial Conversion Feature						$ 3,000
Amortization of Debt Discount (Premium)																																594
Debt Instrument, Interest Rate, Stated Percentage						12.00%
Debt Instrument, Payment Terms						If the Company prepays the Power Up Note 9 within 30 days of its issuance, the Company must pay all of the principal at a cash redemption premium of 110%; if such prepayment is made between the 31st day and the 60th day after the issuance of the Power Up Note 9, then such redemption premium is 115%; if such prepayment is made from the sixty first 61st to the 90th day after issuance, then such redemption premium is 120%; and if such prepayment is made from the 91st to the 180th day after issuance, then such redemption premium is 125%. After the 180th day following the issuance of the Power Up Note 9, there shall be no further right of prepayment.
Power Up Note 9 [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)						$ 0.00006
BHP Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount			$ 38,500
Debt Instrument, Increase, Accrued Interest																																329
Convertible Notes Payable																														38,500		38,500
Debt Instrument, Convertible, Terms of Conversion Feature			In the event the Company has not paid the BHP Note in full prior to 180 days from the issuance date, BHP may convert all or a portion of the outstanding principal of the BHP Note into shares of the Company’s common stock at a price per share at a price equal to the higher of the variable conversion price or $0.00006 per share.  The variable conversion price shall mean 55% of the lowest traded price of the Common Stock during the 25 trading day period ending on the last complete trading day prior to the date of conversion. BHP may not convert the BHP Note to the extent that such conversion would result in beneficial ownership by BHP and its affiliates of more than 4.99% of the issued and outstanding Common Stock.
Debt Instrument, Convertible, Beneficial Conversion Feature			$ 3,000
Amortization of Debt Discount (Premium)																																522
Debt Instrument, Interest Rate, Stated Percentage			10.00%
Debt Instrument, Payment Terms			In the event the Company prepays the BHP Note beginning on the issuance date through the 180th day following the issuance date, the Company must pay BHP all of the outstanding principal and interest due plus a cash redemption premium ranging from 135% to 150%. After the 180th day following the issuance date, there is no further right of prepayment by the Company. BHP has no right of conversion under the BHP Note for a period of 180 days commencing on the issuance date.
Debt Instrument, Maturity Date			Mar. 04, 2020
BHP Note [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)			$ 0.00006
Armada Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Face Amount		$ 38,500
Debt Instrument, Increase, Accrued Interest																																253
Convertible Notes Payable																														$ 38,500		38,500
Debt Instrument, Convertible, Terms of Conversion Feature		In the event the Company has not paid the Armada Note in full prior to 180 days from the Armada Issuance Date, Armada may convert all or a portion of the outstanding principal of the Armada Note into shares of the Company’s common stock at a price per share equal to the higher of the variable conversion price or $0.00006 per share. The variable conversion price shall mean 55% of the lowest traded price of the Common Stock during the 25 trading day period ending on the last complete trading day prior to the date of conversion. Armada may not convert the Armada Note to the extent that such conversion would result in beneficial ownership by Armada and its affiliates of more than 4.99% of the issued and outstanding Common Stock.
Debt Instrument, Convertible, Beneficial Conversion Feature		$ 3,000
Amortization of Debt Discount (Premium)																																255
Debt Instrument, Interest Rate, Stated Percentage		10.00%
Debt Instrument, Payment Terms		In the event the Company prepays the Armada Note beginning on the issuance date through the 180th day following the Armada Issuance Date, the Company must pay Armada all of the outstanding principal and interest due plus a cash redemption premium ranging from 135% to 150%. After the 180th day following the Armada Issuance Date, there is no further right of prepayment by the Company. Armada has no right of conversion under the Armada Note for a period of 180 days commencing on the Armada Issuance Date.
Debt Instrument, Maturity Date		Mar. 10, 2020
Armada Note [Member] | Minimum [Member]
Note 5 - Debt (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)		$ 0.00006
Principal [Member] | Power Up Note 2 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																33,000
Principal [Member] | Power Up Note 3 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																38,000
Accrued Interest [Member] | Power Up Note 2 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																1,980
Accrued Interest [Member] | Power Up Note 3 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																2,280
Principal [Member] | July 2018 RU Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																30,000
Principal [Member] | Power Up Note 1 [Member]
Note 5 - Debt (Details) [Line Items]
Repayments of Debt																																10,236		$ 27,764
Principal [Member] | Power Up Note 4 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																33,000
Principal [Member] | Autus Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																23,209
Accrued Interest [Member] | July 2018 RU Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																3,344
Accrued Interest [Member] | Power Up Note 1 [Member]
Note 5 - Debt (Details) [Line Items]
Repayments of Debt																																58		$ 2,236
Accrued Interest [Member] | Power Up Note 4 [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																1,980
Accrued Interest [Member] | Autus Note [Member]
Note 5 - Debt (Details) [Line Items]
Debt Conversion, Original Debt, Amount																																$ 8,301

XML

Note 6 - Stockholders' Deficit (Details)		3 Months Ended		6 Months Ended
	Apr. 23, 2018 USD ($)	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($) shares	Jun. 30, 2018 USD ($) shares
Note 6 - Stockholders' Deficit (Details) [Line Items]
Stock Issued During Period, Value, Issued for Services			$ 245,580	$ 17,480	$ 248,765
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) | shares				1,000,000	800,000
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture				$ 10,000	$ 40,120
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition				$ 25,093
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares				1,401,224
Debt Conversion, Original Debt, Amount				$ 74,104
Gain (Loss) on Extinguishment of Debt		$ (26,924)	0	$ (26,924)	0
Stockholders' Equity, Other Shares (in Shares) | shares				75,000
Stock Issued During Period, Value, Other			$ 22,900	$ 7,500	$ 22,900
Common Stock Cancelled, Previously Issued (in Shares) | shares				400,000
Convertible Debt [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Number of Equity Transactions				13
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares				5,278,069
Gain (Loss) on Extinguishment of Debt				$ (158,659)
Principal [Member] | Convertible Debt [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Debt Conversion, Original Debt, Amount				177,365
Accrued Interest [Member] | Convertible Debt [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Debt Conversion, Original Debt, Amount				$ 19,385
Accounts Payable [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares				4,405,123
Debt Conversion, Original Debt, Amount	$ 96,000			$ 432,733
Gain (Loss) on Extinguishment of Debt				$ 36,100
Services [Member]
Note 6 - Stockholders' Deficit (Details) [Line Items]
Stock Issued During Period, Shares, Issued for Services (in Shares) | shares				200,000
Stock Issued During Period, Value, Issued for Services				$ 17,480

XML

Note 7 - Stock Options (Details) - Share-based Compensation, Stock Options, Activity - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation, Stock Options, Activity [Abstract]
Options Outstanding, Shares	67,879		67,879
Options Outstanding, Weighted- Average Exercise Price	$ 21.40		$ 21.40
Options Outstanding, Weighted- Average Remaining Contractual Term	3 years 244 days	4 years 62 days	5 years 62 days
Options Outstanding, Aggregate Intrinsic Value		$ 0	$ 0
Options Exercisable, Shares	67,879
Options Exercisable, Weighted- Average Exercise Price	$ 21.40
Options Exercisable, Weighted- Average Remaining Contractual Term	3 years 244 days
Options Exercisable, Aggregate Intrinsic Value	$ 0
Options Granted, Shares	0	0
Options Granted, Weighted- Average Exercise Price	$ 0	$ 0
Options Cancelled, Shares	0	0
Options Cancelled, Weighted- Average Exercise Price	$ 0	$ 0
Options Outstanding, Shares	67,879	67,879
Options Outstanding, Weighted- Average Exercise Price	$ 21.40	$ 21.40

XML

Note 8 - Stock Warrants (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule of Stockholders' Equity Note, Warrants or Rights [Abstract]
Warrants, Outstanding	1,167,653		142,653
Warrants, Outstanding Weighted-Average Exercise Price	$ 0.10	$ 2.18	$ 17.42
Warrants, Outstanding Weighted-Average Remaining Contractual Terms	4 years 6 months	4 years 131 days	1 year
Warrants, Exercisable	1,425,000
Warrants, Exercisable Weighted-Average Exercise Price	$ 0.10
Warrants, Exercisable Weighted-Average Remaining Contractual Terms	4 years 6 months
Warrants, Granted	400,000	1,025,000
Warrants, Granted Weighted-Average Exercise Price	$ 0.10	$ 0.10
Warrants, Granted, Weighted-Average Remaining Contractual Terms	4 years 6 months	4 years 339 days
Warrants, Expired	(142,653)	0
Warrants, Expired Weighted-Average Exercise Price	$ 17.42	$ 0
Warrants, Outstanding	1,425,000	1,167,653

XML

Note 9 - Commitments and Contingencies (Details) - USD ($)							6 Months Ended
	Jul. 03, 2019	Oct. 18, 2018	May 18, 2017	Nov. 04, 2016	Sep. 23, 2016	Dec. 16, 2015	Jun. 30, 2019	Dec. 31, 2018
Note 9 - Commitments and Contingencies (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)							1,401,224
Debt Conversion, Original Debt, Amount							$ 74,104
Loss Contingency, Damages Sought						The complaint seeks damages in the amount of $177,270, inclusive of attorney’s fees, costs and accrued interest, continuing interest in the amount of 12% per annum and attorney’s fees and costs of collection relating to the case.
Loss Contingency, Damages Sought, Value			$ 241,828			$ 177,270
Loss Contingency, Damages Awarded, Value				$ 75,000	$ 48,500
Settlement Liabilities, Current							$ 75,000
Estimated Litigation Liability, Current								$ 241,828
Stree Free Capital [Member]
Note 9 - Commitments and Contingencies (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)							1,401,224
Debt Conversion, Original Debt, Amount							$ 84,073.48
Former Service Provider Vs. Company [Member]
Note 9 - Commitments and Contingencies (Details) [Line Items]
Loss Contingency, Damages Sought, Value		$ 44,365
Estimated Litigation Liability, Current							$ 55,366
Litigation Settlement, Amount Awarded to Other Party		44,365
Litigation Settlement Interest		$ 11,001
Litigation Settlement, Expense	$ 5,000

XML

Note 10 - Subsequent Events (Details) - Subsequent Event [Member]	1 Months Ended
	Jul. 31, 2019 USD ($) shares
Note 10 - Subsequent Events (Details) [Line Items]
Stock Repurchased and Retired During Period, Shares (in Shares) | shares	300,000
Crown Bridge Note 3 [Member]
Note 10 - Subsequent Events (Details) [Line Items]
Proceeds from Convertible Debt	$ 36,000
Debt Instrument, Face Amount	40,000
Debt Instrument, Unamortized Discount	$ 4,000
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Debt Instrument, Convertible, Terms of Conversion Feature	becomes convertible at any time following the 180th calendar day after the issue date at a price per share equal to 55% of the lowest trading price for the Company’s common stock for the twenty-five days prior to the conversion date
Power Up Note 10 [Member]
Note 10 - Subsequent Events (Details) [Line Items]
Proceeds from Convertible Debt	$ 35,000
Debt Instrument, Face Amount	38,000
Debt Instrument, Unamortized Discount	$ 3,000
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Debt Instrument, Convertible, Terms of Conversion Feature	becomes convertible at any time following the 180th calendar day after the issue date at a price per share equal to 55% of the lowest trading price for the Company’s common stock for the twenty-five days prior to the conversion date
Power Up Note 5 [Member]
Note 10 - Subsequent Events (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	586,704
Debt Conversion, Original Debt, Amount	$ 18,000
Crown Bridge Note [Member]
Note 10 - Subsequent Events (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	360,000
Debt Conversion, Original Debt, Amount	$ 10,197
Autus Note [Member]
Note 10 - Subsequent Events (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	1,000,000
Debt Conversion, Original Debt, Amount	$ 29,050
Covnersion 1 [Member] | Power Up Note 5 [Member]
Note 10 - Subsequent Events (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	377,834
Debt Conversion, Original Debt, Amount	$ 15,000
Conversion 2 [Member] | Power Up Note 5 [Member]
Note 10 - Subsequent Events (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | shares	523,560
Debt Conversion, Original Debt, Amount	$ 20,000